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Abstract
According to the CDC the prevalence of Autism Spectrum Disorder (ASD) in
males compared to females is approximately 5:1. Skuse et al. hypothesized that
imprinted genes on the X chromosome could account for this sex bias. Genomic
imprinting is defined as differential gene expression dependent upon the parental origin
of the allele. While genomic imprinting on autosomes has been well classified, no
imprinting mechanism on the sex chromosomes has been discovered. This work
presents an investigation into the regulation of expression governing the imprinted locus
of X-Linked Lymphocyte Regulated 3b/4b/4c (Xlr3/4), and closely linked ASD candidate
gene, Transketolase-Like 1 (TKTL1), in the developing central nervous system of the
laboratory mouse. Examination of epigenetic signatures and the chromatin environment
including differential DNA methylation, differential nucleosome positioning, H3.3
deposition and G-quadruplex formation, suggests that epimutations in these loci may
underlie disease association.
Transketolases play a pivotal role in the Pentose Phosphate Pathway (PPP), and
dysfunction in the non-oxidative phase of the PPP has been linked to
neurodegenerative disorders and cancers. This work explores the expression of TKTL1
in human brain sub-regions of ASD patients compared to neurotypical individuals as
well as the functional role TKTL1 plays in the PPP. It is observed that TKTL1 may not

Glenn Milton
University of Connecticut
2018
function as a transketolase in the pathway, but may play a critical regulatory role as a
competitive inhibitor.
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Chapter 1: Introduction
Overview
The CDC reports there is approximately a 5:1 ratio in the occurrence of Autism
Spectrum Disorder (ASD) in males compared to females, but the reason for this male
bias is currently unknown1. Dr. David Skuse’s X-linked imprinting theory proposes that
this bias is due to the presence of an imprinted gene(s) on the X chromosome 2. In
mammals, imprinted genes are distinguished by the fact that they exhibit parent-specific
gene expression (PSGE). Currently, approximately 200 imprinted genes have been
identified in mammals3, however only six genes showing PSGE have been identified on
the mouse X chromosome and none have been reported for the human X
chromosome4.
In 1997 Skuse et al. theorized that the presence of imprinted genes on the X
chromosome may explain a parent-of-origin associated social cognitive deficiency seen
in patients with Turner Syndrome (TS), i.e. X chromosome monosomy. Skuse et al.
observed decreased social cognitive ability in TS females who inherited the maternal X
chromosome (45XM) compared to 45,XP TS females2. From this work a research path
emerged to investigate X-linked imprinted genes that may play a role in social cognitive
function and neurodevelopment. At the time only a few dozen imprinted genes were
known and all were autosomally linked.
In 2005, Raefski and O’Neill reported the discovery of the first X-linked imprinted
cluster of genes including Xlr3b, Xlr4b, and Xlr4c on the mouse X chromosome (which
will hence be referred to as the Xlr3/4 locus)5. While imprinting at autosomal loci was
known to be regulated by parent-specific methylation at critical Differentially Methylated
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Regions (DMRs), no DMR has been identified at this Xlr3/4 locus, suggesting a novel
imprinting mechanism exists to maintain the imprinting status of these genes. Evidence
to date suggests the chromatin environment could play a role in the PSGE mechanism
seen at the Xlr3b/4 locus.
In addition to DMRs autosomal imprinted genes can be distinguished by the
presence of other allele-specific epigenetic marks. The regulation and maintenance of
PSGE at autosomal imprinted loci is accomplished, in general, by well-characterized
mechanisms utilizing DMR’s and specific histone modifications6. Imprinting mechanisms
for many autosomally imprinted genes have been well studied and are well understood.
However, an imprinting mechanism for sex chromosome linked genes has yet to be
identified and characterized.
This work explores the hypothesis that Xlr3b, Xlr4b, and Xlr4c are imprinted by a
previously unidentified mechanism that does not involve the classic epigenetic marks
known to exist at autosomal imprinted loci. Additionally, this work explores the
hypothesis that Tktl1 in mice and TKTL1 in humans modulates the activity of the PPP in
a way that could contribute to neurodegeneration in ASD. Further, this work provides
insight into the overall chromatin environment of the X chromosome allowing for
analysis of previously unknown differences between the maternal and paternal X
chromosome in mammals.
Specific questions addressed in this dissertation include:
1) Are nucleosomes positioned differently in a parent specific manner at the
Xlr3/4 locus?
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2) Are there parent-of-origin specific differences in open chromatin and thus
different Transcription Factor (TF) binding motifs at the Xlr3/4 locus?
3) Is TKTL1 expressed significantly different among Autistic and neurotypical
brain sub-regions?
4) What is the functional relationship between Tkt (the canonical mammalian
transketolase) and its X-linked paralog, Tktl1 and how do they influence the
Pentose Phosphate Pathway (PPP) in neuronal cells?

3

Background
Autism Spectrum Disorder (ASD)
A prevalent gender bias has been observed in several neurodevelopmental
disorders and, of particular interest, in ASD. A 5:1 male to female ratio has been
reported by the CDC, and in several studies a ratio as high as 7:1 has been seen in
high-functioning ASD subjects7. The prevalence of ASD is approximately 1 in 59
children in the US and between 1-2% worldwide according to the CDC data and
statistics. From genome-wide association studies (GWAS) and exome and wholegenome sequencing of simplex and multiplex families with autistic individuals, both rare
and common variants in over 100 genes have been implicated in the etiology of ASD 8.
Along with genetic factors, environmental factors are believed to play a significant role
in the development of ASD9. At a cellular level, oxidative stress has been implicated as
a contributing factor in ASD development stemming from a link between increased
intracellular free radicals and neurodegeneration10.
The most recent description and differential diagnosis of ASD arises from the
Diagnostic and Statistical Manual V (DSM-5), since its release in 201311. The disorder
typically manifests in symptoms including impaired communication and social
interactions. The Autism Society also lists the following characteristics as
signs/symptoms of ASD: lack or delay in spoken language, repetitive use of language
and/or motor mannerisms, little or no eye contact, lack of interest in peer relationships,
lack of spontaneous or make-believe play, and persistent fixation on parts of objects12.
Currently, early intervention behavioral testing can significantly improve autistic
individual outcomes by conducting a developmental screening of infants and working
4

with multidisciplinary teams to identify the needs of the child. However, understanding
the underlying genetic component of ASD could lead to earlier intervention and
potentially pharmacologic therapy targeted to the disorder.
Neurons due to their high metabolic rate and reduced ability for cellular
regeneration, are particularly sensitive to oxidative stress compared to other organs and
cell types. This susceptibility to damaging effects of reactive oxygen species (ROS) has
linked oxidative stress and neurodegenerative disorders such as Alzheimer’s disease
and ASD. Ultimately, an increase in ROS leads to lipid peroxidation and the breakdown
of cellular membranes13. Particularly of interest to this work is the function of
transketolases during the non-oxidative phase of the PPP. Transketolase catalyzes the
reversible conversion of glucose-6-phosphate to ribulose-5-phosphate in the nonoxidative phase of the PPP, and as a consequence, is responsible for the production of
NADPH. NADPH production is essential for ROS protection in neuronal cells.
Transkeolase activity in the PPP, therefore, may play a pivotal role in managing
oxidative stress and, by extension, ensuring proper neurodevelopment 14,15.
As stated before, potentially contributory variants in over 100 genes have been
linked to the occurrence of ASD. Genes that have been linked to ASD include; RELN,
important for intercellular connections in the nervous system 16, HOXD117, important for
brain structure formation, genes involved in the production of Gamma-amino-butryic
acid (GABA), an important neurotransmitter18, and SLCC6A4, a serotonin transporter
gene important for serotonin equilibrium in synapses18. The gene, HOXA1 has been
well studied and is essential to the development of cranial nerves, brain structures and
the skeleton of the head and neck. Ingram et al. showed that a variant form of the
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HOXA1 (A/G) gene occurred at a frequency of approximately 40% in ASD patients
compared to the frequency of 10-25% in neurotypical individuals of European and
African origin. Interestingly, this HOXA1 variant gene of interest displayed a gender
effect of 11:10 (A/G to A/A) in females and 23:44 in males. It is suggested by Ingram et
al. that this HOXA1 variant effect may be more apparent in females than males, where
all affected females were A/G variant heterozygotes17. A statistically significantly larger
proportion of affected offspring inherited the maternal G allele. It was concluded from
segregation data that the parental source of the allele is important in the occurrence of
ASD19.
The sex differential in the HOXA1 variant association with ASD may be an
example of what is termed, the Female Protective Effect (FPE) that was formulated to
explain the sex bias in occurrence of ASD and other neurodevelopmental diseases 20,21.
The underlying theory of the FPE is that females have an inherent defense against
certain disorders due to the action of sex hormones, or to the presence of two X
chromosomes compared to the single X in males (paired with a Y chromosome). It has
been reported that females diagnosed with ASD display numerous de novo DNA
mutations compared to males21. In essence, for females to present an ASD phenotype,
the threshold for ASD manifestation is higher. This protection may result from X
chromosome mosaicism due to mammalian dosage compensation via X chromosome
inactivation (XCI). XCI in karyotypically normal females constitutively silences one
randomly chosen X chromosome, the resulting mosaicism in females provides a built in
defense mechanism for detrimental recessive X-linked mutations21. If a predisposing
variant is inherited by a female on a single X chromosome, only approximately 50% of
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cells would ultimately express the variant, while males carrying the variant would
express it in all cells. In this way, the female is protected from potential region specific
deleterious effects of variant alleles.
Evidence of a Social Cognitive Deficit Associated with X Chromosome Parent of
Origin
The FPE could begin to explain the occurrence of the male bias in ASD. Females
would be inherently protected from social cognitive deficits associated with the X
chromosome due to random X inactivation. Another theory proposed to explain why
there is a high prevalence of ASD in males is the Extreme Male Brain (EMB) theory20.
Baron-Cohen et al. hypothesize that autism is a manifestation of hyper-masculinized
brain development. EMB invokes the involvement of Fetal Testosterone (fT), where
increased levels of fetal androgens affect sex differences in behavior, cognition, brain
structure and function20. This theory would explain how females are protected from
higher rates of ASD and why males are susceptible. However, currently no concrete
evidence exists connecting increased androgen levels and patients with ASD. With this
lack of evidence, it has been hypothesized that differences on the X chromosome, such
as the epigenetic environment, may explain the skewed prevalence of males diagnosed
with ASD.
This X chromosome hypothesis was first suggested by Dr. David Skuse after
studying females with Turner Syndrome2. Turner Syndrome is the result of either total or
partial X monosomy and patients share several symptoms with those diagnosed with
ASD22,23. Skuse tested the social cognitive function of TS females first via a first-stage
screening survey, then neurological assessments2. These neurological assessments
included the Weschsler Intelligence Scales for Children, the Weschsler Adult
7

Intelligence Scales-Revised and the Test of Everyday Attention for Children. These
tests were scored and their results showed that females in the study that inherited the
maternal X chromosome (45,XM) performed significantly worse than those females who
inherited the paternal X chromosome (45,XP), (Figure 1). From these results, he
suggested that an imprinted gene or gene cluster on the X chromosome could account
for the parent-of-origin difference in TS social cognitive impairment, and, furthermore,
could explain the skewed prevalence of ASD in males2. This was the first report in the
literature to invoke an epigenetic explanation for the sex bias in ASD.

Figure 1: Skuse et al. Social Cognitive Ability
Graph of social cognitive ability of Turner Syndrome Females inheriting either 45,XM or
45,XP compared to 46,XX and 46,XY individuals. The higher score on this test indicates
lower social cognitive ability. 45,XM females displayed the lowest levels of cognitive ability
while 45,XP individuals displayed similar social cognitive abilities to that of males. 46,XX
females scored best on the social cognitive test. Adapted from Skuse et al, 19972.

The Epigenetic Effect and ASD
Epigenetics encompasses the study of hereditable gene expression changes that
do not involve changes to the DNA sequence. Epigenetic effectors in mammals include
methylation of cytosines at CpG dinucleotides, and biochemical modifications to
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nucleosomal histone proteins such as acetylation, methylation, phosphorylation, and
ubiquitination24. Each one of these epigenetic marks can influence gene regulation in
the cell. The term “epigenotype” was first coined by C.H. Waddington to describe how
external factors, such as the environment, can have an effect on an organism’s
phenotype25. In addition to Skuse’s X imprinting theory, evidence of a strong
environmental component to the overall susceptibility of ASD was identified in studies of
both monozygotic and dizygotic twins26,27. In order to understand the influence of
epigenetics on the development of ASD, it is important to consider epigenetic influences
on gene expression in the broadest of sense.
One of the earliest observations of epigenetic gene regulation came from studies
of position effect variegation in the fruit fly, Drosophila melanogaster in which
experiments showed that a gene’s proximity to densely packed regions, or
heterochromatic regions, of the chromosome can influence the overall expression levels
of the gene28. Heterochromatic DNA is characteristically inaccessible to transcription
factors and are generally silent domains due to the conformation of the chromatin in a
dense state28. Another epigenetic phenomenon observed in maize involves an
interaction of two alleles where one allele causes heritable changes in the second allele,
without changing the DNA sequence, this is referred to as a paramutation29. The earliest
epigenetic phenomenon studied in mammals focused on the mechanism that regulates
X chromosome dosage compensation between males and females. In this process, a
random X chromosome in XX females is silenced to reduce the genomic content to
equal the XY male30. The epigenetic marks associated with this silencing event are
discussed later in the chapter. Finally, genomic imprinting is known to be regulated by
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epigenetic marks determining parent-of-origin specific gene expression, which will be
examined further in the following section31.
Evolutionary Origin of Genomic Imprinting
Genomic imprinting involves the differential expression of genes depending upon
which parent contributed the allele, and is often termed Parent-Specific Gene
Expression (PSGE). PSGE has been most often observed in mammals32 and in seedbearing plants33. The relevance of genomic imprinting to neurodevelopment and
behavior in mammals comes about through understanding how it evolved. The original
rationale to explain the evolution of imprinted genes involved a theory of parental
investment (PI) in relation to both the parent and the offspring34. This theory addressed
the conflict that arises between each parent’s optimal PI into each mating 34. In
mammals, as in seed-bearing plants, the development of offspring is supported by
physical resource input from maternal tissues, while the paternal input is purely genetic.
A prevailing theory in the field, known as the Parent-Offspring Conflict model, or Kinship
theory, addresses the issue that although parental genetic contributions are equivalent,
the amount of resource investment into the development and growth of the offspring is
unequal34. The paternal genome can evolve ways to exploit the maternal input, while
the maternal genome counter-adapts. The Parent-Offspring Conflict model explains the
observation that most paternally imprinted (silenced) genes are growth suppressors,
while most maternally imprinted genes are growth enhancers34. Pomiankowski
hypothesized that due to the maternal and paternal X pattern of inheritance, where the
paternal X is always passed to the female offspring and the maternal X is passed similar
to autosomes, the X chromosome is pre-adapted to be regulated by imprinting. This
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theory addresses X-linked imprinting as a response to selection pressure differences
between males and females. The hypothesis is based on the asymmetry of inheritance
of the maternal and paternal X chromosome and provides insight as to how X-linked
imprinting may have evolved differently than autosomal imprinted genes following the
Parent-Offspring Conflict model35.
The fact that the parental genomes display functional inequality, creates in
essence a roadblock to asexual reproduction in mammals meaning both parental
genomes are essential for the developing organism36,37,38. Parental marks established in
the germ line on individual alleles are crucial for the proper expression of genes
throughout development38. One of the first mammalian epigenetic marks identified was
parent-specific differential methylation39. Differential DNA methylation marks are
established in the parental germ lines and are reset in a sex specific manner in each
subsequent generation40.
In terms of evolution, the Parent-Offspring Conflict model argues that paternal
alleles aim to increase the input of maternal resources into developing young to gain a
competitive advantage for their offspring from that specific mating (i.e. more resources,
bigger, stronger offspring). Maternal alleles however, aim to reduce resource output per
litter or offspring to ensure future viable mating. A female is able to contribute her
genomic material to all of her offspring through successive matings with several males,
whereas the male genome aims to optimize the survival of the offspring from only his
mating. In essence, paternal alleles evolved an epigenetic program to maximize
maternal output from a single breeding, while maternal alleles regulate to spread
resources over several matings41. The result of this evolutionary conflict is the silencing
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of the maternal alleles of fetal growth enhancing genes and silencing of the paternal
alleles for growth suppressing genes42. As discussed below, mutations affecting normal
imprinted expression of these genes not only affect growth patterns, but also adversely
affect neurodevelopment.
Genomic Imprinting in the Context of Disease
Errors in balancing the genomic conflict inherent between the maternal and
paternal genome have been associated with several disorders43,44. Understanding how
these disorders arise may provide insight into how imprinted loci can influence ASD
development. Loss of genomic imprints leading to inappropriate activation or silencing
of both alleles severely alter gene dosages and can result in deleterious effects for the
developing organism. Prader-Willi Syndrome45 and Angelman Syndrome44 are often
caused by a deletion event on human chromosome 15. This deletion specifically occurs
at the 15q11-q13 region and depending upon which parental allele experiences the
deletion, the symptoms are very different46. A deletion of genes on the paternal
chromosome 15 is responsible for the development of Prader-Willi Syndrome and
Angelman Syndrome is caused by a deletion of a gene on the maternal chromosome
1547. Due to the parent of origin specific deletion in these disorders, it was theorized that
an imprinted locus was interrupted on chromosome 1547. Further research revealed
that, in a subset of cases, uniparental disomy was responsible for the disorders48. This
is consistent with the theory that these diseases involve genomic imprinting because the
individuals would inherit identical imprinting marks on both alleles thus disrupting normal
PSGE. The imprinted gene primarily associated with Angelman Syndrome, UBE3A, is
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an ASD candidate gene; furthermore, patients with Angelman Syndrome exhibit autistic
features49.
Genomic Imprinting and Behavior
The influence of imprinted genes on behavior was investigated by Champagne et
al. using a Peg3 knockout mouse model50. Peg3 is a maternally imprinted and
paternally expressed gene on mouse chromosome 7 that is strongly expressed in the
placenta and the developing organism. Behavioral changes were observed in Peg3
mutant female mice as well as a disruption of reproductive success. This result was
dependent on the genetic background of the maternal mouse. Characteristics displayed
by the Peg3 mutant mice included lower olfactory discrimination, reproductive success,
pup retrieval, and postpartum licking/grooming. The mutant offspring displayed
impairment in both sucking and growth rate compared to wild type (WT). Interestingly,
the group also observed an effect of Peg3 mutant mice on their non-mutant female
offspring suggesting there is a mode of transmission of effects without transmission of
the mutant allele. It is believed the behavioral differences in the mother caring for her
pups is responsible for this mode of transmission50. A recent study led to the
identification of a gene in mouse, pleckstrin homology-like domain family A member
2 (Phlda2), that influences the hormones produced by the mother during pregnancy51.
This gene negatively regulates a portion of the placenta and is dependent on dosage of
Phlda2 in the offspring. Expression differences of this gene were observed to cause
changes to the maternal hypothalamus and hippocampus during pregnancy and altered
maternal care for pups after birth. Paternal silencing of Phlda2 caused increased
nurturing of pups suggesting that paternal silencing of this gene evolved to increase
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maternal care51. This study provides evidence for how genomic imprinting of genes can
be directly linked to behavior. Furthermore, it provides evidence that imprinted genes
are involved in Parent-Offspring conflict, where the paternal genome influences the
maternal output of resources, such as nurturing, to ensure survival of offspring.
With imprinted genes associated with behavior and Pomiankowski’s theory of a
pre-adapted X chromosome for genomic imprinting, Skuse et al.’s theory of X-linked
imprinted genes underlying the difference in social cognitive ability in TS female patients
is supported by data found the literature. Identification of X-linked imprinted genes
responsible for X-linked imprinting and the underlying imprinting mechanism, may
provide insight into the direct link of X-imprinted genes and neurodevelopmental
disorders. The following section describes current understanding of characterized
mechanisms of autosomal genomic imprinting.

Underlying Imprinting Control Mechanisms
Since imprinted genes have been implicated in ASD, it is important to understand
the underlying mechanisms that control this parent specific expression. The following
describes what is currently known in the literature about two autosomal imprinted gene
clusters and their regulation. The best characterized of these genes is Insulin like
growth factor II (Igf2)52,53. This gene is maternally silenced and paternally expressed on
mouse chromosome 7. The imprint was discovered after disruption of Igf2 expression
by gene targeting in mice produced differing results depending on whether the knockout
was transmitted through the maternal or paternal germ line. When Igf2 expression was
altered in the paternal germ line, the resulting offspring displayed adverse
characteristics52. However, this was not the case when the gene was altered in the
14

maternal germline52. This observation suggested that a parent specific expression effect
may be occurring at the locus. Subsequently, a DMR was observed in the promoter of
the gene H1953, which is closely linked to Igf2 on mouse chromosome 753. At this locus,
the paternal allele is methylated while the maternal allele is unmethylated, and H19
shows a pattern of PSGE opposite that of Igf253. Igf2 and H19 were observed to utilize
the same enhancer elements downstream of H19 to regulate gene expression of
opposing parental alleles53. The protein CTCF binds to the unmethylated maternal allele
upstream of H19 and acts as an insulator allowing the enhancer elements to interact
with the promoter and drive gene expression of H19. On the paternal allele, the region
is methylated, CTCF cannot bind, and the enhancer elements are used by Igf2 to
express the gene (Figure 2). To determine if this DMR was in fact the imprinting control
region (ICR), deletion experiments were conducted to elucidate if expression of the
parental alleles were altered54,55. It was concluded that the identified DMR was
responsible for regulating proper imprinting at the locus54,55.

Figure 2: Igf2/H19 Imprinting Mechanism
Methylation of CpG islands on the paternal allele of the Igf2/H19 locus. Due to this
methylation CTCF is unable to localize and downstream enhancers loop 100kb to interact
with Igf2. The ICR is unmethylated on the maternal allele allowing CTCF to bind upstream
of the H19 promoter. CTCF acts as an insulator, preventing enhancers from looping back
to transcribe Igf2 and instead drive expression of the non-coding RNA H19.
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Differential methylation is one mechanism governing genomic imprinting at
autosomal loci. Another mechanism involves the transcription of a long non-coding RNA
transcript that can regulate imprinted expression56. One well-studied example of this
mechanism is the transcription of a non-coding RNA, Airn, which regulates expression
of the imprinted genes Igf2r, Slc22a2, and Slc22a357. Interestingly, a non-coding RNA is
produced at the H19 locus, however, evidence shows this non-coding RNA is not
responsible for establishing the imprint at the Igf2 locus58. To date, no sex-linked
genomic imprinting mechanism has been identified. Understanding the underlying
imprinting mechanism of X-linked genes could help explain the findings of Skuse et al.
and provide insight into future therapies for X-linked imprinting disorders.
DNA Methylation and DMRs
Defects in DNA methylation have been implicated in disorders including cancer 59
and neurodevelopmental disorders such as schizophrenia60 and ASD61. Most commonly
in mammals, DNA methylation involves the addition of a methyl group to the 5’ carbon
of a cytosine residue by a DNA Methyltransferase (DNMT)62. As stated previously, DNA
methylation is an epigenetic mark that can be altered to change the phenotype of an
organism without changing the underlying DNA sequence. This mark is known to
influence processes including X Chromosome Inactivation (XCI), carcinogenesis, and
genomic imprinting by regulating DNA accessibility and regulating expression 62. DNA
methylation is common and in general occurs in the mammalian genome at
approximately 1% of cytosines49. Typically, high levels of methylation are seen at what
are called CpG islands. The generally accepted characteristics of a CpG island are
regions where the observed to expected ratio of CG nucleotides is greater than 60% in
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200 bp of sequence63. About 85% of the time, these CpG islands are located near the
promoters and transcription start sites (TSSs) of genes. In the case of the Igf2/H19
locus, differentially methylated transcriptional regulatory domains regulate gene
expression in a parent-of-origin specific manner64,65. DNA methylation often blocks the
binding of transcription factors, thus rendering the region silent66. During mammalian
pre-implantation development, there is a wave of genome-wide demethylation followed
by lineage-specific methylation that maintains cellular identity and genomic stability67.
However, ICRs manage to remain methylated during this event in the developing
embryo68. In this way, ICRs are preserved to regulate genomic imprinted loci and
establish the baseline for parental allele differentiation. This process is maintained by
DNA methyltransferase, Dnmt169.

Mammalian Dosage Compensation
The sex chromosomes are of particular interest in neurodegenerative disorders
including ASD, which presents a sex bias in diagnosis frequency. Specifically, gene
expression on the X chromosome is implicated in social cognitive deficiencies 2. In
mammals, males are the heterogametic sex with an X and Y chromosome. The
evolutionary origin of the mammalian sex chromosomes is thought to be an autosomal
pair that acquired a sex-determining trait70,71. When organisms are heterogametic for
sex chromosomes with an unequal amount of genomic material, a method must evolve
to normalize the transcriptional output between the two sexes72. This method is known
as dosage compensation and this process has evolved differently in several organisms.
For example, in Drosophila melanogaster, the male inherits only a single X
chromosome. To equalize expression to the female (XX), the male upregulates gene
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expression on the single X two-fold73,74. The nematode worm, C. elegans, utilizes a
different dosage compensation mechanism: the hermaphroditic organisms (XX) reduce
the expression of each X by half so as to equal the expression levels of the male with
one X chromosome75,76. Important to this work, female mammals, accomplish dosage
compensation by randomly silencing a single X chromosome in a process known as X
Chromosome Inactivation (XCI)77. This process is required to balance the uneven
genomic material present on two X chromosomes compared to the males X and Y. The
Y chromosome in most cases is small and gene poor compared to the X
chromosome78,79,80.
X chromosome silencing actually occurs in two separate phases. First, a
preferential silencing of the paternal X chromosome occurs in the preimplantation
embryo81. This silencing is reversed in the early blastocyst and both X chromosomes
are once again active82. After this point, to accomplish dosage compensation by XCI,
the silencing mechanism first begins at a region known as the X chromosome
inactivation center83. The number of X chromosomes are counted within the cells by
molecular machinery to begin XCI84. The long non-coding RNA transcript Xist then
begins to be produced by the X chromosome randomly selected to be silenced. On the
active X chromosome, the antagonistic long non-coding RNA Tsix is produced
preserving the active status of the allele85,86. The silenced X chromosome is condensed
into a heterochromatic state by the Xist transcripts coating the chromosome and
recruiting epigenetic modification to render it inactive. The inactive X chromosome is
referred to as the Barr Body which remains inactive and locates to the periphery of the
cell87,88. Interestingly, the overall methylation between the silenced and active X
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chromosomes remains the same, however, CpG islands on the silenced X are shown to
be hypermethylated89. This hypermethylation of CpG islands should silence
transcription at normally active genes. Evidence has shown that histone H2A.1 is
essential for XCI and is preferentially loaded into nucleosomes on the inactive X
chromosome to ensure a persistent silent state90,91. This is one line of evidence of
nucleosomes, and histone proteins influencing gene expression on the X chromosome.
The random inactivation of either of the two parental X’s in female eutherian
mammals during XCI means that normal females are mosaics, carrying groups of cells
differentially expressing a parental X in all tissues92. However, during fetal development,
the placenta preferentially silences the paternal X while the maternal X remains active93.
Interestingly, marsupials preferentially silence the paternal X in all tissues throughout
the life of the organism94,95.
While autosomal imprinted genes are expressed equally between sexes, X
inactivation results in an additional layer of complexity in terms of genomic imprinting.
Skuse et al. and Raefski et al. explained that X-linked imprinted genes are not believed
to be expressed equally between the sexes2,5. Due to the unequal expression of genes
on the sex chromosomes, a maternally silenced X-linked gene would not be expressed
in males. Conversely, a maternally expressed/paternally silenced X-linked imprinted
gene would be expressed in all male cells while only in half of the cells in females due
to XCI mosaicism. This would lead to higher expression of maternally expressed and
paternally silenced genes in males compared to females. Having this imbalance of gene
expression from genomic imprinting could result in sex specific differences96,97,98,99.
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Raefski Development of Turner Syndrome Model Mice
Raefski and O’Neill utilized a TS mouse model to generate X monosomic mice
where the X chromosome parental lineage could be tracked and studied 3. The Patchy
Fur (Paf) strain caries a large inversion on the X chromosome leading to a high
frequency of sex chromosome nondisjunction during meiosis in
spermatogenesis. Male Paf mice mated
with wild type C57 female mice produce
39,XM genotype in 25% of progeny. The
InX strain also carries a large X inversion
that leads to non-disjunction of the X’s
during oogenesis. C3H/InX female mice
bred with a wild type C57 males
produces a 39,XP genotype

Figure 3: X Monosomic Mouse Breeding
Scheme
Breeding generated 39,XM ~25% of offspring
and 39,XP ~20% of offspring

approximately 20% of the time (Figure
3) (the C3H/InX hybrid females are used to distinguish XC3H/XC57 or XInX/XC57 females
from monosomic XC57 females)5.
Using neonatal brain RNA from these monosomic mice to perform a
transcriptomic screen, a gene cluster at XA7.2 was identified to be imprinted,
comprising three paralogs of the X-Linked Lymphocyte Regulated (Xlr) family of genes.
Subsequent experiments showed that this imprinted locus was not regulated by a DMR
and further experiments were conducted to investigate the underlying imprinting
mechanism of the Xlr locus. To date, no sex-linked imprinted genes have been shown
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to be regulated by a DMR suggesting that a novel imprinting mechanism exists for the
Xlr imprinted cluster(86,89,91,92). The Xlr imprinting cluster and underlying imprinting
mechanism will be discussed further in the following chapters.
After the initial discovery of the Xlr imprinted locus, Dr. Inga Nesbitt screened
surrounding genes on the mouse X chromosome to identify other potentially X-linked
imprinted loci. A candidate gene was identified downstream of the Xlr cluster,
Transketolase-Like 1 (Tktl1), that displayed a partial imprint in both olfactory bulb and
neonatal neocortex. Follow-up experiments investigating the imprinting status and
function of Tktl1 and its human ortholog TKTL1, its imprinting status, and overall
function will be addressed further in the following chapters.
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Chapter 2: The Imprinted X-Linked Lymphocyte Regulated Locus (Xlr)
Characterization of the First X-Linked Imprinted Locus (Xlr)
The dosage compensation mechanism of the sex chromosomes in mammals
presents an additional layer of complexity to parent specific effects. For this reason, in
many published GWAS and genetic linkage studies the X chromosome is frequently
ignored100, leaving a gap in knowledge surrounding sex-linked imprinted genes. Until
2005, imprinted genes on the X chromosome had yet to be identified in mammals.
Publishing back-to-back in the same issue of Nature Genetics, Raefski and O’Neill,
along with Davies et al. published the discovery in mice of the imprinted gene Xlr3b5,99.
While Davies only identified this one gene, Raefski was able to determine imprinting
status of two additional closely linked genes, Xlr4b and Xlr45. The Xlr genomic
organization at this region consists of three triads, Xlr3a/b/c, Xlr4a/b/c and Xlr5a/b/c.
Only three of the nine genes in this cluster have been identified as imprinted, and no
other member of the Xlr superfamily displays evidence of genomic imprinting. As
discussed in the previous chapter, Dr. Raefski utilized a TS mouse model to generate X
monosomic mice to examine the expression levels on the individual parental X
chromosome employing a gene expression microarray screening approach. Using these
mice, he determined all three imprinted genes are maternally expressed and paternally
silenced in mouse neonatal brain (Figure 4), and later showed this pattern in mouse
primary fibroblast cells (data not shown).
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Figure 4: Discovery of the Imprinted Xlr3/4 Region
Real-Time PCR results of 40,XX, 39,XM, 39,XP, and 40XY mouse transcripts identifying
genomic imprinting of the genes Xlr3b, Xlr4b, and Xlr4c. Maternal X expression and paternal
X silencing is noted. Raefski and O’Neill 20053.

There are multiple clusters of Xlr genes scattered across the rodent X
chromosome. All Xlr genes are derived from the single copy autosomal gene
Synaptonemal Complex Protein 3, Sycp3. Sycp3 plays a critical role in meiosis,
comprising the axial elements of the synaptonemal complex101. While Xlr-like gene
clusters have been identified on most of the sequenced X chromosomes of eutherian
mammals, the only Xlr-like genes found in primates are the FAM9 genes located at the
human Xp22.3 region. While the Xlr3/4/5 cluster is specific to rodents, the Xlr3/4 genes
have homologs on the X chromosomes of elephant, dog, and swine, suggesting that
Xlr3/4 are the most ancient members of the Xlr superfamily. The Xlr3/4/5 triad is present
in five closely linked copies with their orientation suggesting segmental duplications are
responsible for the multicopy organization of the genes102. The Xlr3, Xlr4, and Xlr5
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genes share approximately 30% sequence similarity in protein-coding regions. All
paralogous Xlr3 copies code for nearly identical proteins and share a coding nucleotide
sequence similarity over 90%. The extremely high sequence conservation of the Xlr3
paralogs is also true for the Xlr4 and Xlr5 paralog groups, respectively.

Figure 5: X-Linked Lymphocyte Regulated (Xlr3/4) Locus
Illustration of the X‐linked Lymphocyte Regulated (Xlr) locus at XA7.2 (mm10). Red indicates
imprinted genes.

Functional Study of the Xlr3b Protein
Most research about the Xlr3/4 region revolved around the characterization of the
imprinting mechanism regulating gene expression at the locus. More recently, work
conducted by R. Foley in the O’Neill lab aimed to elucidate the function of the protein
products of the Xlr3 paralogs103. Utilizing amino acid alignments to visualize protein
domains, Xlr3b was observed to contain a so-called COR1 domain. The COR1 domain
has an unknown function, but is conserved in the Synaptonemal Complex Protein 3
(Sycp3) protein104,105. During meiosis, homologous chromosomes exchange genetic
information during crossing over before segregation and this process is regulated by the
Synaptonemal Complex (SC). Due to the shared COR1 domain between Xlr3b and
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Sycp3 and the fact that Xlr3 mRNA is highly expressed in testis, Dr. Foley investigated
the potential role of Xlr3b in spermatogenesis and meiosis.
While quantitative real-time PCR (qRT-PCR) showed expression of the Xlr3b
transcript as early as spermatogonial stages, Western blot analysis using an antibody
that recognizes all XLR3 protein products showed expression of the XLR3 protein first
detected during early prophase of meiosis I. Spermatocyte and embryonic ovary cell
surface spreads were used to view the localization of the XLR3 protein by
immunohistochemistry (IHC). In meiotic oocytes, XLR3 was observed localizing to
Nuclear Organizing Regions (NORs). During spermatogenesis, XLR3 was observed
localizing to the XY body, a compartment in the meiotic prophase I nucleus containing
the inactivated X and Y chromosomes. Compartmentalization and inactivation of the X
and Y chromosomes occurs in male meiosis and is referred to as Meiotic Sex
Chromosome Inactivation (MSCI). While the role of XLR3 in MSCI is currently
undefined, Sycp3 is known to play an essential role in the establishment of MSCI.

Regulation of the Imprinted Xlr Cluster
Investigating the imprinting mechanism of the Xlr3/4 cluster may provide insight
into how parent specific expression on the sex chromosomes is regulated at other as
yet unidentified loci. As stated previously, the majority of autosomal imprinted genes are
regulated by Imprinting Control Regions (ICRs), typically demarcated by a differentially
methylated region (DMR) governing the chromatin state of the parental alleles. Using
this as a starting point, a former member, B. Carone, attempted to identify a DMR
regulating the Xlr3/4 locus106. DNA methylation was analyzed via bisulfite sequencing of
predicted CpG islands in a ~250 kilobase region including the three non-pseudogenous
25

Xlr3/4/5 clusters (i.e. all of the A, B, and C paralogs). The results, as shown in Figure 6,
showed hypermethylation at both the non-imprinted and imprinted paralogs of both
parental alleles.

Figure 6: Methylation Status at the Xlr Imprinted Cluster
Bisulfite sequencing analysis results of CpG island clones associated with the Xlr
paralogs. Unmethylated CpGs are unfilled (white) “lollipops” while methylated are
filled in black. Figure from Carone, 2008.
Following these results, the search expanded to regions further up and
downstream of the Xlr3/4 cluster. ICRs are known to regulate distal parental expression
of genes such as in the Igf2/H19 imprinted region. In fact, approximately 90kb of
sequence separates the ICR of this locus and the Igf2 promoter107. To investigate distal
regions, M. Murphy of the O’Neill lab conducted immunoprecipitation of methylated DNA
from monosomic neonatal brain samples (MeDIP) followed by hybridization to
Affymetrix tiling arrays of the mouse X chromosome108. While MeDIP identified a
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potential DMR upstream of Xlr3b this result could not be replicated by bisulfite
sequencing (data not shown).
In the absence of a detectable DMR, S. Kasowitz of the O’Neill lab investigated
the Xlr3b primary transcript to determine if PSGE was achieved by a cotranscriptional/RNA processing mechanism109. He noted that while Xlr3b equally
initiates transcription equally from both parental alleles, by exon 7, the transcript on the

Figure 7: Xlr3b Primary Transcript Analysis
qRT-PCR of Xlr3b primary transcripts assayed at varying locations in the gene body.
Uniform 39,XM primary transcript compared to lack of transcript on 39,XP allele in neonatal
brain at Intron 7. Figure from Kasowitz, 2011.

paternal allele is virtually undetectable via qRT-PCR (Figure 7). This would mean some
mechanism interrupts proper transcription elongation on the paternal allele. Conversely,
a mechanism may exist that removes an obstacle to transcription elongation on the
maternal allele allowing for the full transcript to be produced.
To determine if PSGE of Xlr3b is governed at the level of transcription elongation
or transcript processing, former O’Neill lab member S. Qureshi investigated the
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chromatin architecture and RNA Polymerase II (RNA Pol II) occupancy on the maternal
and paternal alleles of Xlr3b by performing Chromatin Immunoprecipitation on
neocortex of monosomic neonatal mice. RNA Pol II was equally enriched on both
parental alleles at the 5’ end of the Xlr3b transcription unit. However, a peak of
enrichment of the Serine 2-phosphorylated RNA Pol II (actively elongating) was
observed on the paternal allele at the Intron3/Exon4 boundary compared to the
maternal allele. At intron 7, Ser2-RNA Pol II was more enriched on the maternal allele.
This data is in agreement with the primary transcript qRT-PCR, and suggests that
transcription is initiated on both alleles, but that elongation stalls somewhere in the
middle of transcription on the paternal allele. It is important to note that the paternal
allele-specific RNA Pol II stall at Intron3/Exon4 revealed by these ChIP experiments has
not been replicated in further experiments. Therefore, the molecular nature of the Xlr3b
imprint is still unknown.
Dr. Foley set out to investigate differential methylation in surrounding regions of
the imprinted cluster, particularly the methylation status of Factor 8 associated gene A
(F8a). In doing so, he opened the door to a potential DMR residing directly within the
imprinted cluster itself. Dr. Foley was first interested in F8a when ENCODE released
ChIP data observing CTCF binding motifs within the 5’ end of F8a. The very same
insulating protein present at the most well studied imprinted locus, Igf2/H19, was
positioned within the Xlr imprinting cluster of genes. CTCF is known to create chromatin
loop structures to orchestrate enhancer/promoter interactions and also functions in
important regions as an insulator. Also of note, the ENCODE tracks identified a p300
known enhancer flanking the CTCF site in F8a. These CTCF binding sites reside within
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the F8a gene body along with a CpG island that was not previously investigated by
former lab members. In fact, a portion of the CpG island was indeed analyzed, but did
not incorporate the CTCF binding sites.
Dr. Foley decided to investigate the methylation status of this CTCF binding site
associated with the CpG island. His results can be found in Figure 8 and depict
differential methylation with a methyl sensitive PCR assay. Dr. Foley found that
surrounding the CTCF binding site were differentially methylated CpG’s where XM was
hypermethylated and XP was hypomethylated. Using bisulfite sequencing he
determined a subtle methylation difference of approximately 4% differentiated the
maternal and paternal allele. To explore whether this DMR located in F8a regulated
Xlr3/4 expression, he performed a
CRISPR deletion of the CTCF
binding site. However, no effect
was observed on the overall
imprint. Work conducted to
further understand this
functional mechanism
regulating Xlr3/4 will be
discussed in the following
chapters.

Figure 8: HpaII Methylation Assay at F8a
HpaII sites in neonatal whole brain analyzed. HpaII
cutting at sites would produce no band
hypomethylation. No cut would produce positive band
and indicate hypermethylation.
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Chapter 3: Chromatin Architecture at the Imprinted Cluster Xlr3/4
Region
Bionano Methylation of XA7.2
Thus far a novel X chromosome imprinting mechanism has yet to be discovered.
As discussed in the preceding chapter, previous members of the O’Neill lab assayed the
CpG island methylation status of regions surrounding the Xlr3/4 imprinted genes via
bisulfite sequencing and MeDIP/microarray and found no differential methylation. Dr.
Murphy’s MeDIP initially identified a differentially methylated region upstream of Xlr3b
but subsequent bisulfite sequencing of this site revealed no allele-specific methylation. It
has been shown in previous studies such as the investigation of the H19/Igf2 locus that
it is not required for a DMR to be proximal to the imprinted gene. The genes Igf2 and
H19 are approximately 70 kb apart and are regulated by the same DMR110.
Concerns in the O’Neill lab that previous methylation screens were insufficient to
identify distal DMRs motivated a series of follow up experiments utilizing a new
approach. To accomplish a wide range methylation profile of the XA7.2 region and also
the entire X chromosome, an assay was developed for the Bionano Genomics Irys
platform. The Bionano platform utilizes nanochannel technology in coordination with
restriction enzyme cut site fluorophore incorporation to be read by a laser within the
instrument. The general purpose of the Irys is to create large molecule (≥150 kb)
fragments to be aligned to a restriction enzyme digested genome to create a scaffolding
backbone for assembly and sequencing analysis111. Expanding on this concept, the
laboratory of Dr. Yunal Ebenstein in Tel Aviv developed a methylation detection protocol
to be used on the Bionano Irys system. In collaboration with the Ebenstein lab and the
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laboratory of Dr. Elmar Weinhold in Germany, I modified the Bionano Genomics
protocol to enable visualization of methylated sites with the Irys system 111,112.

Figure 9: Bionano Methylation Assay Alignment
Bionano methylation sensitive assay aligned to a CMAP file for BspQI (Bionano supplied
enzyme). Bionano molecule alignment analysis with IrysView software from Bionano
Genomics of genomic region ChrX:73,000,000-73,750,000 containing Xlr imprinted cluster
(A.) and genomic region ChrX:100,000,000-103,600,000 (B.) representing a higher quality
molecule alignment with the software. Xlr3b is highlighted in the blue boxes on the maternal
and paternal alleles. Due to shearing events caused by the additional methylation steps of
the protocol, molecule alignment results were lower than expected. The software needed to
allow for smaller fragments causing lower mapping rates. XM mapping 28.1% of molecules
and XP mapping 14.3% of molecules.

39,XM and 39,XP samples were prepared with the Bionano Prep Blood and Cell
Culture DNA Isolation Bundled Kit following the Bionano Genomics protocol for high
molecular weight DNA isolation. Samples were labeled with the cofactor AdoYnCF640R
(gift from Dr. Elmar Weinhold lab)113 with M.TaqI followed by knick labeling with
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Nt.BspQI enzyme as a part of the Bionano NLRS protocol. M.TaqI is a
methyltransferase enzyme with a recognition site, TCGA. M.TaqI methylates the
adenine residue within this sequence, and can be used to incorporate a labeled
cofactor. However, if the CpG within the recognition sequence is methylated, the
reaction is blocked114. Samples were run on the Bionano Irys instrument and images
were captured and interpreted by the Bionano Irysview software package. A molecule
quality report was produced for high molecular weight molecules and alignment to the
digested mm10 reference genome (CMAP) was performed, followed by mapping
assembly. Molecules were mapped by matching of restriction digest labeled regions
incorporated via the Nt.BspQI restriction enzyme provided by Bionano Genomics. In this
way, large DNA molecules are knick labeled at known restriction enzyme digest regions
of the genome and fragments are aligned based on distance calculated between
incorporated labels viewed in the nanochannel. Molecules depicted in Figure 9 show
these alignment to the reference genome. In (A) the Xlr3/4 region is visualized with
minimal coverage by large DNA molecules and in (B) a different region of the X
chromosome is shown with higher coverage. The tool utilized by the Ebenstein lab to
analyze the incorporated methylation fluorophore, Irys Extract, requires deeper
coverage, and thus visualization of the methylation status on the X chromosome was
unable to be accomplished with this platform.
Images generated by the Irys Extract software would have allowed visualization
of the fluorescently labeled DNA molecules for a given chromosomal region. Had this
assay produced non-sheared DNA molecules, Irys Extract could have identified which
molecules mapped to the reference genome at the Xlr3/4 locus and provided insight into
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the methylation status between the maternal and paternal alleles. The molecules were
stained green for the Nt.BspQI restriction sites and red for methylated cytosines by
M.TaqI. Without high quality large DNA molecules, a sufficient Molecule Quality Report
could not be generated for the data to allow for further analysis.
DNA was sheared due to the additional step of labeling the molecules with the
methylation sensitive cofactor AdoYnCF640R. Shearing was determined by the average
length of DNA fragments being <150 bp during analysis. This resulted in fewer
molecules mapped to the reference and minimal coverage across the genome as seen
in Figure 9. The methylation status across the X chromosome environment remains
elusive and awaits further analysis. DNA handling steps for future methylation sensitive
assays should be minimized to reduce potential shearing. Simply adding one additional
mixing step was enough to shear DNA molecules. If more pervasive information about
the overall methylation environment of the X chromosome is desired, I would not
suggest using the Bionano Genomics platform for future studies. The Nanopore MinION
could be used to discern differences in DNA methylation across the X chromosome.
This technique utilizes bioinformatics tools to identify differing ionic current signals on
methylated versus unmethylated cytosines and adenosines114.
Nucleosome Positioning at XA7.2
Chromosome composition can affect transcription by influencing the ability of
transcription initiation and elongation by RNA Pol II115. Nucleosomes present a physical
barrier that can cause backtracking/arrest of RNA Pol II during active transcription and
are known to regulate the access of cellular transcription machinery to DNA loci 116.
Typically, the transcription machinery can overcome this arrest by the incorporation of
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specific functional histone variants. Nucleosome rich regions are difficult for RNA Pol II
to transcribe through and are often associated with RNA Pol II strand dissociation,
meaning a dense region of nucleosomes near the Xlr3b intron3/exon4 boundary could
explain the stalling event previously seen on the paternal allele 117,118.
ChIP analysis by S. Qureshi in the O’Neill lab appeared to reveal an RNA Pol II
stalling event during transcription of the Xlr3b gene on the paternal allele. Dr. Qureshi
also found enrichment of H3K36me3 at the precise location of the RNA Pol II stalling
event on the paternal Xlr3b via ChIP. Dr. Qureshi’s ChIP results formed the rationale for
experiments to map nucleosome positioning at the Xlr3/4 locus. MNase-Seq was used
to investigate nucleosome positioning in the Xlr3/4 region. However, recently Dr.
Qureshi’s data has not been able to be replicated by current members of the lab. While
the stalling event is now in question, the following nucleosome positioning assays were
conducted with the RNA Pol II stalling hypothesis in place.
Analysis of Nucleosome Positioning by MNase-Seq
Nucleosome positioning and occupancy has been implicated in influencing gene
expression by impeding transcription in various ways. It has been shown that
nucleosomes can inhibit activator binding and the formation of the preinitiation complex
(PIC) as well as preventing proper elongation in transcription119. Micrococcal nuclease
is an enzyme used to digest double-stranded, single-stranded, circular and linear
nucleic acids. In particular micrococcal nuclease is unique due to its ability to cause
double stranded breaks and digestion of nucleosome linker regions while leaving the
nucleosome region intact120. Utilizing the function of this enzyme, nucleosome positions
are able to be determined. Genome-wide nucleosome occupancy maps (NOMs) have
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been developed121; the X chromosome, however, often presents unique challenges to
allele specific experiments and the data tends to be unreliable due to the additional
complexity of X inactivation and heterogametic sex chromosomes. Using the 39,XM and
39,XP Mus. musculus TS model mice, I was able to sequence the single X chromosome
and compare the nucleosome profile between the maternal and paternal X
chromosome.
Neocortex brain tissue was extracted from neonate 39,XM and 39,XP Mus
musculus neonates and chromatin was isolated in biological triplicates. Micrococcal
nuclease was used to digest double stranded DNA not bound to histone proteins and
DNA fragments were target enriched using cRNA baits specific to the XA7.2 region of
the mouse X created from Agilent SureSelect probes122. Library construction was done
for the Illumina MiSeq platform and produced paired end 150 bp reads after adapter
sequence trimming. Fasta and Fastq files were produced and a FastQC quality report
was generated to assess read quality (Appendix Figure 1). Paired end reads were
aligned and indexed to the mm10 Mus musculus genome using Bowtie2.
Many short read mappers could be used such as BWA and Bowtie2 123. Bowtie2
was used for this experiment because of the use of genome indexing, a computational
strategy utilizing a Burrows-Wheeler transformation to speed up the alignment
algorithm. This indexing technique can compress a reference genome to save memory
while still enabling efficient read alignment. Bowtie aligns each read one base pair at a
time to the Burrows-Wheeler transformed genome until alignment of the entire read is
accomplished. This mapping algorithm, although much more complicated than others,
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has been shown to be up to 30 times faster enabling high quality mapping in less
time124.
Unique mapping is achieved in Bowtie2 by passing nucleotide mismatches and
quality parameters to allow a single read to map to one location in the genome. This
unique mapping is part of the default parameters of Bowtie2. Due to the high sequence
similarity of the paralogous Xlr family of genes, unique mapping would result in the
exclusion of nearly all reads in the region that do not contain a paralog specific single
nucleotide polymorphism (SNP). Due to this, a different non-unique mapping approach
was required for analysis of the MNase-Seq data. Since paralog specificity could not be
achieved by this approach, any differences observed between the parental alleles are
assumed to be associated with the imprinted paralog. Biallelically expressed paralogs
would likely not display differences between parental alleles whereas monoallelic
expression would be accomplished by differences between the parental alleles. All
reads were called, mapped and then visualized in IGV125,126 for a profile of nucleosome
occupancy across the Xlr3/4 region, creating a nucleosome map across the paralogs.
With the high sequence similarity, normalizing the reads was essential to examine the
differential enrichment of nucleosomes between 39,Xm and 39,Xp neocortex brain
samples. This was achieved utilizing the R package normR127. Bam alignment files and
indexed files were imported into R and treated as control (39,Xm) and treatment (39,Xp).
I hypothesized that 39,Xp would have differential nucleosome positioning interfering with
successful RNA Pol II transcription through the gene body.
Mapping was followed by data analysis with R packages including nucleR, PING
and normR127,128,129. NucleR compiles all reads and filters with a threshold peak calling
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of 25% and creates a bed file output that can be visualized on the UCSC Genome
Browser. Additionally, PING was used to display a nucleosome occupancy map (NOM)
providing a graphical depiction of the nucleosome positioning data in a designated
genomic frame. This analysis processes the reads of a specified size and uses a peak
detection script creating a peak score determined by a 25% threshold. Figure 10 depicts
the NOM of Xlr3b across the 39,XM and 39,XP gene body generated by PING. Finally,
normR was used to normalize reads between the sample sets. Numerically identified
neonate samples XM73, XM86, XM91, XP100, XP148 and XP175 were concatenated into
large XM and XP BAM files for this portion of the analysis. NormR utilizes a script to
normalize reads between two data sets against background. DiffR is a script in the
normR package that can be used for enrichment analysis in ChIP-Seq and alike
datasets and here was used to determine enrichment of reads between X M and XP
samples. The read counts are modeled as a binomial mixture model, meaning the
datasets were analyzed for the presence of differing sub-regions and applied to a
binomial distribution. Significance was set in the script to P ≤ 0.001 and all remaining
reads were depicted in an output BED file and visualized in IGV (Figure 11).
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Figure 10: MNase-Seq Nucleosome Occupancy Map (NOM)
Nucleosome occupancy map for Xlr3b generated from MNase sequencing reads from
39,XM and 39,XP neocortex samples. Reads generated from MNase-Seq treated
samples and run on Illumina Mi-Seq Overall profile of nucleosome occupancy peaks
similar between XM and XP. R package PING used to generate occupancy maps.
Output threshold 25% peak calling per package guide. All graphs from
ChrX:73192179−73202930 to depict Xlr3b in mm10.
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Figure 11: MNase-Seq Data Analysis
Nucleosome occupancy enrichment at the imprinted Xlr locus, F8a and Spin2d (both
biallelically expressed). Blue bed file bars represent enrichment of nucleosomes on the
paternal allele while red represent enrichment of nucleosomes on the maternal allele
Enrichment analysis done in R with normR package and diffR script. All enrichment had
a p-value of p=0.001.
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An enrichment of nucleosomes on the 39, XP allele is observed juxtaposed to the
stalling event initially seen by Dr. Qureshi. Additionally, this enrichment includes a
portion of SINE-B4 element associated with imprinted genes in mouse. SINE-B4
elements have been shown to be enriched in maternally active and paternally silenced
imprinted gene loci130. The presence of this known associated repetitive element
coupled with enrichment of two nucleosomes positions of the paternal allele within this
SINE-B4 element could be associated with an imprinting control mechanism on the X
chromosome.
Where there has been no discernable differential methylation in the region of the
Xlr3/4 imprinted cluster, some other mechanism must be controlling the expression
status of these alleles. A potential RNA Pol II obstacle in the form of enriched
nucleosomes on the paternal allele could govern the expression of the Xlr imprinted
genes. Very few differences between the alleles have been identified previously, and
this statistically significant difference highlighted in Figure 11 in the green boxes could
very well be associated with an imprinting control mechanism on the X chromosome.
Nucleosomes prevent the progression of RNA Pol II productive elongation on the
paternal allele by creating a physical barrier to the transcription machinery. RNA Pol II
machinery has been shown to stall and dissociate from genomic regions in previously
reported experiments131.
This MNase-Seq experiment was a critical step in identifying differential
nucleosome positioning at the Xlr3/4 locus. However, due to the use of Agilent
SureSelect probes prior to this analysis, only a small target region of the X chromosome
was evaluated with this analysis. A whole X chromosome survey was suggested using
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the 39,XM and 39,XP model mice. While MNase-Seq generates quality data, only
nucleosome positioning information can be analyzed from the resulting data. A newer
technique, Assay for Transposase-Accessible Chromatin using sequencing (ATAC-Seq)
allows for nucleosome positioning data, and also open chromatin and DNA footprint
analysis132. For this reason, ATAC-Seq was chosen for the survey of the X chromosome
and will be discussed in the following section.

Open Chromatin and Nucleosome Occupancy
The method of ATAC-Seq utilizes regions of open chromatin and the binding
affinity of transposases to sequence all openly accessible regions of chromatin 131.
Utilizing this sequencing technique, a profile of open chromatin can be created to
examine all regions that are accessible by external machinery for processes including
DNA replication or transcription. This process can also be used to create a nucleosome
positioning profile as DNA that is bound to a histone octamer is not openly accessible
and these regions can be assessed with bioinformatic tools by looking for size specific
regions where dyads and triads exist due to this inaccessibility. Thus, this data can be
used to both map open genomic sequence along with nucleosome positioning. Each
library consists of 50,000 nuclei from frozen M. musculus neocortex tissue and 500 D.
melanogaster nuclei as a spike-in control. These nuclei are extracted following the
Omni-ATAC-Seq protocol from the Chang lab133 that improved upon the previous
ATAC-Seq protocol from the Buenrostro lab134 eliminating the large portion of
mitochondrial DNA captured and sequenced in the original protocol. Nuclei were
isolated using an iodixanol gradient solution to eliminate all other cellular components.
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As depicted in Figure 12, Illumina Nextera transposase is pre-loaded with
adapter recognition sequences that attach to DNA when incubated at 37°C and allow for
open chromatin to be amplified with barcoding and indexing primers for Illumina
sequencing136. Amplification cycles were determined by a Real-Time PCR followed by
library quantification using the KAPA Illumina Library Kit. Finally, a Qbit quantification
was conducted to analyze the concentration of the libraries being pooled for loading
onto the Illumina NextSeq.

Figure 12: ATAC-Seq Protocol
Transposase (Tn5 transposome - Nextera) ligate Illumina adapters to regions of open
chromatin for downstream amplification. JD Buenrostro et al, Nature Methods, 2013.

For nucleosome positioning assays with ATAC-Seq, it is suggested to sequence
approximately fifty million reads per sample137. And for DNA footprint analysis it is
suggested to sequence approximately two hundred million reads per sample137. The
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Illumina NextSeq High Output sequencing kit produces approximately eight hundred
million reads per run. ATAC-Seq was performed on two 39,XM mice and two 39,XP mice
giving approximately two hundred million reads for each sample individually allowing for
DNA footprint analysis to be completed. The Illumina NextSeq 2x75 paired end 75 bp
sequencing kit was used for samples XM291, XM294, XP1044 and XP1053 and
sequences were aligned using Bowtie2 according to the ATAC analysis pipeline
described by the Kundaje lab at Stanford University135.

Table 1

Mapping quality > q30 (out of total)
Mitochondrial reads (out of total)
Final reads (after all filters)

39,XM
84.70%
1.10%
78.60%

39,XP
77.80%
0.80%
73.00%

Paired-end sequencing reads were mapped using Bowtie2 to the mm10 genome
generating a BAM output. Mapping quality can be seen in Table 1. An overall profile of
open chromatin domains was viewed with IGV in Figure 13. 39,XM reads were
normalized to two hundred million to match the amount of reads from 39,XP sequences
before analysis to avoid mapping bias. Regions of differential open chromatin were
identified in Xlr3b between 39,XM and 39,XP upstream of the Int3/Ex4 boundary as seen
in Figure 13. Some differences are noted in the non-imprinted paralogs of Xlr3 and Xlr4
genes (Figure 14), however, the most substantial differences observed were in the
imprinted paralogs at the Xlr3/4 locus. Also analyzed were X-linked biallelically
expressed genes Ddx3x, Sox3, and the imprinted autosomal gene H19, see Figure 15.
Overall open chromatin profiles appear to be consistent, including H19 due to both
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parental alleles being present. While some differences exist in the non-imprinted and
biallelically expressed genes, the data does show a greater difference between the
imprinted genes, comparatively.

Figure 13: ATAC-Seq Profile of the Xlr3 Paralogs
Open chromatin tracks viewed with IGV. Open chromatin mapping of Xlr3a, Xlr3b, Xlr3c.
Open chromatin domain differences highlighted by green boxes. 39,XM (Red) and 39,XP
(Blue) BAM files displaying open chromatin mapping by ATAC-Seq analysis pipeline.
Quantifiable differences of open chromatin observed in the imprinted gene body to be
investigated further with DNA footprint analysis. Substantial difference noted at the 5’ end of
Xlr3b compared to the non-imprinted paralogs. Differential sequencing reads between alleles
for further analysis.

44

Figure 14: ATAC-Seq Profile of the Xlr4 Paralogs
Open chromatin tracks viewed with IGV. Open chromatin mapping of Xlr4a, Xlr4b, Xlr4c.
Open chromatin domain differences highlighted by green boxes. 39,XM (Red) and 39,XP
(Blue) BAM files displaying open chromatin mapping by ATAC-Seq analysis pipeline.
Quantifiable differences of open chromatin observed in the imprinted gene body to be
investigated further with DNA footprint analysis. Differential sequencing reads between
alleles for further analysis.
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Figure 15: ATAC-Seq Profile of Ddx3x, Sox3, and H19
Open chromatin tracks viewed with IGV. Open chromatin mapping of Ddx3x, Sox3, H19.
Open chromatin domain differences highlighted by green boxes. 39,XM (Red) and 39,XP
(Blue) BAM files displaying open chromatin mapping by ATAC-Seq analysis pipeline. Ddx3x
and Sox3 are biallelically expressed genes at different loci on the X chromosome. Overall
profiles of these genes are similar with few if any quantifiable differences. H19 is located on
mouse chromosome 7 and is part of the Igf2/H19 imprinting cluster. Included in analysis to
view open chromatin domains on autosomal locus. Both maternal and paternal alleles are
represented in the data for H19.

ATAC-Seq quality metrics were determined using the ATAC-Seq/DNase-Seq
data analysis pipeline developed by the Kundaje laboratory and open sourced from
GitHub136. Illumina Fastq files were normalized to two hundred million reads for DNA
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footprint analysis. Quality metric outputs displayed in Figures S4&S5. Figures S4&S5 A)
depicts an enrichment plot of ATAC-Seq reads relative to a normalized representative
sample of Transcription Start Sites (TSS’s) while (Figure S4&S5 B) represents an
aggregate of all enrichment of ATAC-Seq reads across all TSS’s in the genome. Overall
read fragment length was observed predominantly below ~150 bp correlating to
nucleosome free regions of open DNA (Figure S4&S5 C). This is important for ATACSeq data analysis to determine accurate capture of open chromatin regions versus
nucleosome bound DNA regions. Sequences obtained from this protocol for both 39,X M
and 39,XP samples passed quality metrics for ENCODE library complexity statistics and
were determined to be high quality reads for nucleosome positioning and DNA footprint
analysis, see Table 2.

Table 2
39,XM
Fraction of reads in universal DHS regions
Fraction of reads in blacklist regions
Fraction of reads in promoter regions
Fraction of reads in enhancer regions
Fraction of reads in called peak regions

# Reads
79,379,373
116,773
20,518,428
58,903,814
37,307,828

% of Total
50.6
0.1
13.1
37.6
23.8

39,XP
Fraction of reads in universal DHS regions
Fraction of reads in blacklist regions
Fraction of reads in promoter regions
Fraction of reads in enhancer regions
Fraction of reads in called peak regions

60,755,132
103,276
13,573,697
47,153,034
23,788,702

46.5
0.1
10.4
36.1
18.2

Nucleosome occupancy is also able to be calculated using ATAC-Seq data using
open chromatin states as a baseline to detect nucleosome protected regions of DNA
(Omni-ATAC)133. A python package, NucleoATAC, developed by the Greenleaf lab at
Stanford University for the purpose of identifying nucleosome occupancy and
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positioning from ATAC-Seq data sets was used on Illumina Next-Seq sequencing data
files137. Sequencing files were aligned as previously described with Bowtie2 to the
mm10 genome. The pipeline configures ATAC-Seq bam alignment files of open
chromatin and analyzes nucleosome protected regions of DNA elucidating nucleosome
positioning with a resulting bedgraph output file138. Output bedgraph files were sorted
with bedtools and then converted to a binary tiled data (.tdf) file for improved IGV
performance and processing due to the large size of the files. Nucleosome positioning
results can be seen in Figure 16 and 17.

Figure 16: Nucleosome Occupancy ATAC-Seq
ATAC-Seq Data analysis with NucleoATAC reveals nucleosome positioning differences
between 39,XM and 39,XP mouse neonate brain samples at Xlr3b region (A). NucleoATAC
pipeline used to analyze normalized sequencing data followed by visualization in IGV.
Overall profile of biallelically expressed F8a (B). Green boxes indicate regions of differential
nucleosome predicted on the paternal allele of Xlr3b by NucleoATAC pipeline. Slight
difference at the 3’ end of the gene F8a noted in yellow.
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Figure 17: ATAC Nucleosome Profile of Biallelically Expressed Genes
A closer look at two biallelically expressed genes at the XA7.2 region. As seen in the
previous image, F8a (A.) displays some level of nucleosome differences in the gene
body. However, at the promoter and 5’ end of the gene, the profiles are almost identical.
Spin2d (B.) displays only a slight difference of nucleosome positioning at the 5’ end.
While there is a slight difference it can be seen that some level of nucleosomes do exist
around the promoter region of Spin2d.

Figures 16 and 17 depict the output data from the NucleoATAC pipeline and
differential nucleosome occupancy was observed between the maternal and paternal
allele of Xlr3b in normalized data. NucleoATAC utilizes the script pyatac to calculate
sequence bias and eliminate reads that are not statistically significant nucleosome
regions139. 39,XP was observed to contain nucleosome peaks where there were none
on the maternal allele. Particularly, these peaks highlighted in green are positioned
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proximal to the int3/ex4 boundary. Previously Dr. Sohaib Qureshi had identified a
potential stalling event of RNA Pol II at this region of Xlr3b. Nucleosomes arranged in
specific locations in a transcript could inhibit proper active elongation of RNA Pol II thus
disrupting completion of transcription. This model could explain the previous findings by
former lab members where transcription initiation is seen to begin, but by intron 7, the
transcript of the paternal allele is no longer present. Similar differences were seen in
Xlr4b/4c however, it was not as drastic as Xlr3b. Also of note, Xlr3a and Xlr3c do not
share this same nucleosome occupancy difference between the maternal and paternal
allele. This appears to be an imprinted cluster paternal allele specific effect at the Xlr3/4
locus. The nucleosome positioning maps generated by both MNase-Seq and ATAC-Seq
displayed regions around the intron3/exon4 boundary and exon 7 enriched on the
paternal allele. This can be seen in Figure 11 highlighted in green boxes from the diffR
analysis and also in Figure 16 (A). Another similar region in Xlr3b across the studies is
intron 1, where there is nucleosomal enrichment identified on the maternal allele.
Overall, ATAC-seq not only gives a more robust view of nucleosome positioning, open
chromatin domains, and DNA footprint analysis, it also produced a sufficient number of
reads to allow for unique mapping. This allows for paralog specificity for the region and
a more in depth view of Xlr3/4 imprinted cluster.
Generally, biallelically expressed genes in the region display less dynamic
nucleosome occupancy across the gene body although it is noted that there are still
some differences (Figure 17). In the case of F8a it has previously been postulated by
members of the lab that differences within the gene such as CTCF binding and a DMR
very well could aide in the imprinting mechanism of the Xlr cluster. The differences seen
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in nucleosome occupancy of F8a could very well be involved in this mechanism allowing
or restricting access of transcription factor binding proteins or potentially, insulator
proteins such as CTCF. Spin2d, the biallelically expressed gene upstream on the X
chromosome has an almost identical nucleosome positioning profile between the
maternal and paternal allele. Only a slight difference is observed at the very beginning
of the gene body. Below in Figure 18, a survey of other regions of the X chromosome
are depicted starting with the imprinted region of Xist and Tsix and surrounding genes.
Several nucleosome occupancy differences are noted between the maternal and
paternal allele. Secondly in Figure 18, Tktl1 displays major differences in nucleosome
occupancy between the paternal alleles. There has been a long standing debate in lab
whether Tktl1 is in fact imprinted, and this data could potentially be a novel discovery in
its imprinting status. The pattern of large nucleosome deserts in one parental allele has
remained consistent across several X chromosome imprinted genes (Figure 18). Finally,
a region of biallelically expressed genes is examined. Subtle differences are noted, but
the presence of large nucleosome deserts are noticeably absent. Five imprinted genes,
Xlr3b, Xlr4b, Xlr4c, Xist, and Tsix all have displayed these nucleosome differences
between parental alleles.
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Figure 18: Survey of Nucleosome Occupancy in Regions of the X Chromosome
Nucleosome occupancy maps generated by ATAC-Seq reads and the NucleoATAC
analysis pipeline for (A.) Xist/Tsix, (B.) Tktl1, Flna, Tex28, (C.) Stk26, Frmd7, Rap2c,
MbnI3 and Hs6st2. Nucleosome occupancy differences noted in blue boxes reflect
differences between the maternal and paternal alleles. Nucleosome deserts noted in
imprinted genes while absent on biallelically expressed genes. All nucleosome
occupancy maps generated with the pipeline with a 95% confidence and normalized
by sequence count.

ATAC-Seq DNA Footprint Analysis
Transcription factor binding motifs are interspersed across the entirety of the
mammalian genome allowing for proper binding of regulatory proteins to interact with
the chromatin and drive or inhibit different stages of transcription140. The ENCODE
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project compiled a database of sequence specific transcription factors (TFSS’s) via
ChIP-Seq and identified strong DNA binding motifs over a large number of cell types
and model organisms141,142,143. ATAC-Seq identifies open chromatin regions of the
genome not bound by nucleosomes which are freely available to bind to regulatory
proteins. In this way, ATAC-Seq reads enable an investigation of regions for DNA
binding protein motif sequences across the entire genome. This can also be achieved
by DNase-Seq, however, recently researchers have begun utilizing ATAC-Seq data to
conduct DNA footprint analysis134.
The MEME suite is designed to identify DNA binding protein motifs from
sequencing data across thirteen different tools. This bioinformatics tool searches
genome sequence files for known protein binding consensus sequences and scores
them according to an e-value144. The e-value is used to eliminate background noise
from the data by determining the number of hits that can be expected by chance when
searching a database of a given size. Essentially, the value decreases exponentially as
the score of a match increases. The lower the e-value, the less likely the scored motif
would occur by chance in the genome.
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Table 3.
Xlr3b
39,XM Motif
39,XP
e-Value
HXB8
1.20E-81
FOXI1
2.10E-10
ZN322
1.60E-09
MTF1
2.40E-09
DDIT3
4.00E-08
NRF1
1.50E-07
SMAD4
1.60E-06
P63
2.40E-06
THA11
1.60E-04
DBP
2.00E-04
STA5A
2.40E-04
CUX2
1.90E-03
SMCA5
2.00E-03
CRX
3.60E-03
ZFP42
9.10E-03
HXA1
2.10E-02
NKX28
2.80E-02
F8a
39,XM Motif
39,XP
e-Value
ZN281
6.2E-456
TGIF1
2.1E-421
SP3
1.1E-323
BHA15
1.0E-214
SP2
4.8E-198
RORA
5.7E-180
ZFX
2.5E-139
HIC1
8.4E-128
KLF6
1.8E-103
LEF1
8.4E-103
INSM1
2.9E-90
MYF6
8.7E-81
ZNF335
4.0E-69
ZIC3
2.1E-67

Motif
STAT1
IRF3
NR2E3
HNF4A
STF1
FOXI1
VDR
SP7
RARA
BACH1
TGIF1
ZKSC1

e-Value
1.20E-119
1.70E-102
9.90E-83
2.00E-04
7.90E-04
2.60E-03
2.60E-03
9.70E-03
1.90E-02
2.60E-02
2.80E-02
3.30E-02

Motif
e-Value
ZN281
5.2E-644
INSM1
9.5E-472
MYF6
1.0E-377
KLF4
1.2E-208
SP3
2.5E-198
SP2
2.5E198
ZN335
7.3E-110
NR1D1
1.1E-104
LEF1
1.4E-77
ZIC3
6.4E-50
EGR1
2.5E-43
MYOD1
3.0E-36

Table 3: Meme-ChIP Output for Xlr3b and F8a
Motif binding site analysis output from Meme-ChIP suite. Open chromatin reads analyzed for
Transcription Factor (TF) binding motifs. Highlighted motifs indicate binding sites similar
between the maternal allele (left) and paternal allele (right). Xlr3b observed with only one
similar motif between parental alleles. Biallelically expressed gene F8a observed with eight
similar motifs.
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Table 3 shows the results of the MEME suite analysis for reads mapped to Xlr3b
and the bialllelically expressed gene F8a from the ATAC-Seq analysis. Although
different parental alleles should be sequence similar, a drastic difference of DNA protein
binding motifs have been identified. Signal transducer and activator of transcription 1
(STAT1)145 and Interferon regulatory factor 3 (IRF3)146 are implicated in the immune
response but have not yet been associated with imprinted genes in the literature.
Nuclear receptor subfamily 2, group E, member 3 (Nr2e3) is a known TF binding protein
that interacts with several other proteins to regulate transcription147,148,149,150. Two
known interactions are with Nuclear receptor co-repressor 1/2 (Ncor1151 & Ncor2152,153)
which have been shown to suppress transcription in mouse. Particularly, these TF
proteins are known to repress transcription by chromatin condensation151,152,153.

Figure 19: Protein Interaction Map of Nr2e3
Graphical protein interaction map of TF binding protein Nr2e3 found on the paternal
allele of Xlr3b in mouse. Map shows known interactions of Nr2e3 with other TF proteins
that influence transcription. Courtesy of String Consortium.

55

IRF3 has been shown to bind to the TF E1A binding protein p300 (Ep300) which
functions as a histone acetyltransferase and regulates transcription via chromatin
remodeling154. Contrary to the transcriptionally silent state of the paternal allele of Xlr3b,
Ep300 acetylates all four core histones in nucleosomes that gives an epigenetic tag for
transcriptional activation. It is thought that acetylation of histone H3 at Lysine-122
(H2K122ac) stimulates transcription by possibly promoting nucleosome instability155.
This instability of nucleosomes could account for the dynamic differences between the
maternal and paternal alleles of the imprinted locus. The presence of an Nr2e3 binding
motif on the paternally silenced allele could begin to explain how this allele is
preferentially silenced compared to the expressed maternal allele. However, the
presence of a binding consensus sequence does not necessarily correlate to physical
binding of the protein in vivo.

Conclusions
Although Dr. Foley identified a potential region of differential methylation located
within the F8a gene between Xlr4b and Xlr4c the role of this DMR has yet to be
classified. The previous findings of no differential DNA methylation at the Xlr imprinted
cluster in conjunction with Dr. Kasowitz’s primary transcript data and Dr. Qureshi’s RNA
Pol II stalling event strongly suggested a co-transcriptional process regulating the
genomic imprint at the Xlr3/4 region. However, with Dr. Qureshi’s findings now in
question, the data provided in this work suggests an independent finding. Differential
nucleosome positioning could perturb active transcription throughout the paternal allele,
or perhaps provide a locus for epigenetic marks allowing active transcription on the
maternal allele yet to be identified. While nucleosome positioning has been shown in
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organisms to affect active transcription, it has not yet been shown to be a part of an
imprinting control mechanism in mammals. RNA Pol II stalling events are not unusual
and recently it has been shown that pausing proximal to the genes promotor occurs
early during active transcription but typically at the 5’ region of the gene156. This pausing
is thought to be involved with the process of the transcription machinery adding a 5’ cap
important for translation and RNA stability157. This specific pause however, would not
account for the observation by Dr. Qureshi. Nucleosome positioning is not observed to
be responsible for this stalling mechanism as at the 5’ region of the gene. This would
suggest that nucleosome positioning is not directly involved in overcoming the stall
during transcription initiation. In Figure 20, a nucleosome peak can be seen at the
inton1/exon1 boundary where no peak is detected on the paternal allele. This
differential nucleosome positioning could be a region of interest to the imprinting
mechanism as will be discussed later in this section. This maternal specific nucleosome
peak could allow for specific TF binding proteins to allow active transcription to occur
solely on the maternal allele. How this nucleosome has been positioned differently to
the paternal allele is yet unknown.
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Figure 20: Nucleosome Occupancy ATAC-Seq Xlr3b 5’
Analysis of Xlr3b 5’ region nucleosome occupancy by ATAC-Seq. Sparse placement of
nucleosomes at the 5’ end of the maternal and paternal allele indicative of accessibility for
transcription initiation of both alleles. Peak noted at the intron1/exon1 boundary.

The X chromosome alleles are known to share 100% sequence identity and thus
silencing due to sequence specific stalling or perturbation, which has been observed in
A+T-rich regions, can be ruled out as an influence on the imprinting control
mechanism158,159. Overall nucleosome occupancy at the imprinting cluster displays
differential positioning, seen in Figure 21. Although Dr. Qureshi’s analysis was the
starting point of these experiments, this data stands alone in observing differences
between the maternal and paternal X chromosome.
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Figure 21: Differential Nucleosome Positioning at the Xlr3/4/5 Locus
NucleoATAC nucleosome peaks visualized by IGV at the XA7.2 region across part of the
Xlr paralog superfamily containing the imprinted paralogs (A). Boxes indicate regions of
differentially positioned nucleosomes. Non-imprinted genes do not display distinct
differences compared to imprinted genes. (B) A zoomed in image of NucleoATAC peaks at
the imprinted Xlr genes. Distinct differential positioning of nucleosomes present at the
Int3/Ex4 boundary.

While this differential nucleosome positioning does not by itself establish an X
chromosome independent imprinting control mechanism, it does provide novel insight to
the potential role nucleosome occupancy may play in regulating transcription at
imprinted loci such as Xlr3/4. There were stark differences observed in the DNA TF
binding motifs identified by the MEME suite from my ATAC-Seq data (Table 3). When
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comparing binding sites only one (Foxi1)160 is shared between the maternal and
paternal Xlr3b alleles. This binding motif difference suggests activating and silencing
transcription factors are able to bind to different parental alleles. What remains to be
seen is what causes the regions of open chromatin between the alleles to be different. A
potential nucleosome rearrangement may occur to allow for transcription factor binding
proteins to effectively access the maternal allele. Conversely, the paternal allele could
undergo a nucleosome rearrangement to ensure the silencing of that allele.

Figure 22: DNA TF Meme Suite Output
Depicted are the top three motifs identified by MEME analysis for the Xlr3b gene
sequence for (A) 39,XM and (B) 39,XP. Of the top 13 hits, only one shared motif was
identified (Foxi1). Consensus sequences e-value for each were above 1.60E-09

indicating a high confidence.
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The predominant difference between the two alleles is the parent of origin of the
X chromosome suggests an epigenetic mechanism independent of DNA methylation
causing silencing specific to the paternal allele. This is a novel hypothesis for an
imprinting control mechanism and could be used to identify potential currently
unidentified imprinted genes on both the mouse and human X chromosome in the future
by searching the X chromosome for genes with similar regulatory characteristics. Figure
22 displays a graphical depiction of the consensus sequence for the top three TF
binding domains identified by the MEME suite analysis program. DNA footprint profiles
appear to be very different between parental alleles. In fact out of the top 13 motifs, only
one (Foxi1) was similar.

Figure 23: DNA Footprint Analysis of Xlr3 Paralogs
DNA Footprint of 39,XM (Red) and 39,XP (Blue) for the genes Xlr3a, Xlr3b, and Xlr3c.
Data produced by the python script RGT-HINT. DNA footprints depict model active
binding sites at the TSS of Xlr3a and Xlr3b on the maternal allele. No active binding sites
are detected on any paternal allele. Xlr3c is absent of any predicted active binding
domains. Previously predicted TF binding sites mapped with the Sequence Manipulation
Suite.
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DNA footprint analysis was accomplished using the RGT suite, and specifically
the Hmm-based IdeNtification of Transcription Factor Footprints (HINT) script. This suite
allows for MACS2 peaks to be manipulated to generate detected regions of increased
and decreased histone modification and ATAC signals. It was originally adapted from a
suite tailored for DNase-seq experiments to be used with ATAC-Seq data. This pipeline
uses a bias-corrected signal before normalization steps making it a preferred method for
DNase/ATAC-Seq analysis. Seen in Figure 23 predicted active binding sites proximal to
the TSS can be seen on the maternal allele for Xlr3a and Xlr3b however no active
binding sites are predicted on the maternal allele for Xlr3c. Xlr3a does depict active
binding sites on the paternal allele, however not at the TSS. Xlr3b does not contain any
predicted active sites on the paternal allele.

Figure 24: DNA Footprint Analysis of X Chromosome Genes
DNA Footprint of 39,XM (Red) and 39,XP (Blue) for the genes Ddx3x, Sox3, and Rhox5.
Data produced by the python script RGT-HINT. DNA footprints depict active binding sites
at the TSS of Ddx3x, Sox3, and Rhox5 on both parental alleles. A similar profile is seen
across Ddx3x and Sox3, however, at the 3’ end of the maternal allele of Rhox5 there are
predicted sites and none on the paternal allele.
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As seen in Figure 24, biallelically expressed genes Ddx3x and Sox3 display
virtually identical DNA Footprint profiles. Rhox5, a known imprinted gene, shares a
similar 5’ end between parental alleles. However, the 3’ region displays peaks only on
the maternal allele. The similarity observed between parental alleles of biallelically
expressed genes and the differences observed between known imprinted genes
suggests a potential role of predicted active binding sites at the loci. Further analysis will
need to be conducted to elucidate the role of these binding sites and the transcriptional
activity at the Xlr3/4 locus.
Combining the data from the MNase-Seq assay for maternal and paternal
enrichment with the ATAC-Seq nucleosome positioning prediction shows consistency
between predicted loci, see Figure 25. This overlap between the two assays provides
insight into differentially positioned nucleosomes on the parental alleles. Several loci as
seen in Figure 25 identified originally by MNase-Seq, displayed maternal enrichment
and paternal depletion later in the ATAC-Seq assay. These differentially positioned
nucleosomes could influence the overall transcriptional activity at the imprinted Xlr
locus.
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Figure 25: MNase-Seq Enrichment Comparison to ATAC-Seq Nucleosome Positioning
Nucleosome MNase enrichment of maternal nucleosomes (bottom – red) align with predicted
nucleosomes on the maternal allele from NucleoATAC output. Similarly, paternal enrichment
of nucleosomes (bottom – blue) align with predicted nucleosomes from NucleoATAC.

A recent publication by Shioda et al. examining a mouse knockout of the
chromatin remodeler, Atrx, identified a CpG island in Xlr3b at the intron1/exon1
boundary that appears to be differentially methylated according to the presence or
absence of Atrx161. This CpG island corresponds to the region investigated by B.
Carone that was found to be equally methylated on both parental alleles (Figure 6). This
region was also predicted to form the non-canonical DNA secondary structure know as
a G-quadruplex by the QGRS Mapper162. The knockout of Atrx in hippocampus of adult
male mice upregulated Xlr3b expression161. The group reasoned that Atrx is recruited to
the G-quadruplex region, and in turn, recruits DNA methyltransferases (Dnmts) to
establish a DMR regulating gene expression161,163,164,165. It has previously been reported
that ATRX acts within a histone chaperone complex, along with DAXX to deposit
histone variant H3.3 in heterochromatic regions enriched for H3K9me3 166. In Figure 26,
I identified differential nucleosome occupancy on the maternal allele of Xlr3b aligning to
the same region of this reported G-quadruplex from the Shioda group161. H3.3 has been
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previously shown to be associated with active gene transcription by opening otherwise
compact chromatin regions167.

Figure 26: G-Quadruplex Alignment with Nucleosome Occupancy
Nucleosome occupancy at Xlr3b (A.) and Xlr4b (B.) in relation to the presence of predicted
G-quadruplexes. Both imprinted genes display differential nucleosome occupancy in the 5’
region of the gene body correlating to the location of a high scoring G-quadruplex prediction.
These regions are believed to interact with ATRX acting as a chromatin remodeler by means
of a histone chaperone complex.

As seen in Figure 26, differential nucleosome occupancy on the maternal allele
of the two sense strand imprinted genes in the Xlr locus correspond to predicted Gquadruplex regions. These nucleosomes have the potential to be modified by ATRX
with the deposition of H3.3 causing the maternal allele to be actively transcribed while
the paternal allele would remain silent. An imprinting mechanism involving differential
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nucleosome positioning and ATRX deposition of H3.3 has not yet been identified and
would be a novel discovery. This mechanism would explain the actively transcribed
maternal allele compared to the transcriptionally silent paternal allele.
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Chapter 4: The Transketolase-Like 1 Gene in Neurodevelopment
Discovery of Tktl1 Imprinted Expression in Mouse
Since imprinted genes often occur in large clusters, former O’Neill lab member
A.M. Nesbitt tested genes for PSGE in a 1 Megabase region surrounding the Xlr3/4/5
genes. PSGE of autosomal imprinted genes is generally strongest during embryonic
stages of mouse development168. For this reason, Dr. Nesbitt performed her screen via
qRT-PCR using embryonic liver, brain, and placenta from 39,Xm and 39,Xp mice. She
first detected maternal dominant expression of Transketolase-like 1 (Tktl1) in embryonic
stage 14.5 (E14.5) liver. Dr. Nesbitt then assayed for imprinted expression of Tktl1 in P0
brain sub-regions due to the link of imprinted genes and neurocognitive ability. A five-

Figure 27: Dr. Nesbitt Real-Time PCR results of Tktl1 Expression
A statistically significant difference was observed between the different genotypes in all
tissues analyzed (p<0.05). Error bars indicate a ninety-five percent confidence interval.
Adapted from Dr. Addie Mae Nesbitt.
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fold higher expression was observed in 39,XM neocortex compared to 39,XP along with
an eight-fold difference in olfactory bulb, and two-fold difference in cerebellum (Figure
27). The allelic dominance in expression indicates that Tktl1 is regulated by what is
termed a “partial” imprint.
In conjunction with mouse studies, Dr. Nesbitt assayed allele-specific expression
of TKTL1 in a 46,XX 19 week human fetal brain sample (Figure 28). She again
observed sub-region-specific partial imprinting: noting, for example, a five-fold allelic
dominance in thalamus, and two-fold allelic dominance in frontal cortex. However, the
lack of parental DNA matching this fetal brain sample made it impossible to determine
which parental allele was the more highly expressed.

Figure 28: 19 Week Fetal Human Brain TKTL1 Expression
TKTL1 expression levels in human fetal brain tissue sub regions using c.-44dupT allele
imprinting primer set. Thalamus displays greatest fold difference in 19w Human brain
samples. This data suggested at the time TKTL1 may in fact be imprinted in human
brain as well as mouse brain tissue. This data propelled experiments looking at the link
between TKTL1 and ASD. Adapted from Dr. Addie Mae Nesbitt. *Only one fetal brain
sample was ever obtained for analysis.
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TKTL1 Expression in Human Brain Sub-regions
Skuse et al.2 showed that Turner Syndrome (TS) females who inherited the
maternal X chromosome, 45,XM show lower
social cognitive ability than TS females who
inherited the paternal X chromosome,
45,XP, implicating X-linked imprinted genes
in neurodevelopment of social and
cognitive ability. Furthermore, Skuse
showed TS females that inherited the
paternal X chromosome displayed similar
social cognitive ability to 46,XY males
and control 46,XX females demonstrated
the highest level of social cognitive

Figure 29. Non-Oxidative Phase of the
Pentose Phosphate Pathway: Function of
Transketolase in converting Ribulose 5phosphate and production of NADPH. p.
863 of Biochemistry, by Voet & Voet, 3rd
Edition.

ability2. TKTL1 is a potential candidate
gene involved in poor social cognitive ability due to the role it may play in the production
of NADPH and ribulose-5-phosphate in the Pentose Phosphate Pathway (PPP)169.
Transketolase is the rate limiting step in the non-oxidative phase of the PPP (Figure 29)
responsible for the reversible conversion of ribose-5-phosphate to glucose-6-phosphate
which results in the reduction of NADP+ to NADPH. NADPH is essential for the
reduction of glutathione which in turn is responsible for reducing hydrogen peroxide
(H2O2)170,171. Reducing H2O2 results in a decrease of oxidative stress and
neurodegeneration170,171.
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Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was used to
assess the relative abundance of TKTL1 transcripts present in neurotypical and ASD
human brain sub-region tissue samples. The goal of this analysis was to determine if
there is a correlation between the level of TKTL1 gene expression, or its imprinting
status in sub-regions of the brain and diagnosis of ASD. Post-mortem frozen brain
tissue samples were obtained from the NIH Neurobiobank and RNA was extracted with
Qiagen RNeasy extraction kits. Sample purity and concentration was quantified by
Nanodrop analysis and samples were normalized to 1000 ng RNA per cDNA synthesis
reaction with cDNA Superscript. Samples were analyzed on the BioRad Real Time
Thermocycler using exonic primer pairs designed as depicted in Figure 30.

Figure 30. Primer design for qRT-PCR products in H. sapiens TKTL1
TKTL1-1 (1) forward designed in 5’ UTR/Exon 1, reverse located in Exon 3. TKTL1-3 (3)
designed in Exon 9, reverse located in Exon 11. TKTL1-1 located in Thiamine Pyrophosphate
(TPP) domain. TKTL1-3 located in Transketolase C-terminal domain.

Cycle thresholds from qRT-PCR were imported into Microsoft Excel and fold
change comparing autistic and control samples were calculated using ΔΔC(T)
method172. β-Actin and GAPDH mRNA were used as a reference housekeeping gene
for normalization. A statistically significant difference in relative gene expression was
observed between parietal brain tissues from females diagnosed with ASD compared to
neurotypical females (Figure 31). However, no statistically significant difference was
observed in female occipital, male occipital or male parietal tissue. With the high
prevalence of ASD diagnosed in males, approximately 5:1 ratio compared to females 1,
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we had expected to find high levels of TKTL1 expression in male brain tissue. A
possible explanation, if TKTL1 over-expression is indeed related to the development of
ASD, a threshold effect may occur. Females having one inactivated X chromosome may
escape harmful effects. Whereas in males, having only one X chromosome may be
more vulnerable to these harmful effects. If a female inherits a mutated copy of a gene
on the X chromosome, ~50% of cells will express the aberrant allele. A mutation may
not present as detrimental if it is expressed only in a sub-population of cells. In brain for
instance, if a specific region is affected with an inherited mutation, another region will
not be. When the mutation is located in a region necessitating the proper allele,
detrimental effects will produce a phenotype. Since X inactivation occurs randomly,
there is a protective effect to silencing a potentially deleterious allele. With this in mind it
is possible this statistically significant difference in TKTL1 expression could be indicative
of the potential development in females with ASD.
A significant difference in TKTL1 expression levels between neurotypical and
ASD samples would support the hypothesis of a role for TKTL1 in the
neurodevelopmental defects underlying ASD. Incorrect regulation of TKTL1 could result
in increased amounts of ROS causing lipid bilayer proliferation in neurological cell
membranes. No significant difference between TKTL1 expression levels may indicate
an earlier critical window for TKTL1 in the developing brain. Many genes and
transcription factors have been shown to be necessary during certain developmental
time points in fetal brain development156. During embryogenesis TKTL1 regulation may
be more important for proper neurological development. Quantitative Real Time PCR
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analysis shows increased expression between neurotypical and autistic female brain
samples.

**

Figure 31: Relative TKTL1 expression in control vs. autistic females
Relative expression of TKTL1 using qRT-PCR in female brain. Data transformed using Log10 for
normal sample distribution. All relative expression normalized to β-Actin. A. TKTL1-1 primer set
designed to 5’ end of gene from Exon 1 to Exon 3. Three of four Autistic samples had higher
relative expression compared to neurotypical control samples, however they are not statistically
significant. Levene’s Test: F=8.063, df=6, p=0.03. T-Test: df=6, p=0.156. B. TKTL1-1 primer set
designed to 3’ end of gene from Exon 9 to Exon 11. All Autistic samples had higher relative
expression compared to neurotypical samples. Levene’s Test: F=1.628, df1=6, p=0.249. TTest: df:6, p=0.004.
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TKTL1 Imprinting Status in Human Brain Sub-regions
The conventional experiment to conclusively determine genomic imprinting is the
detection of monoallelic expression of a SNP in a cDNA sample in an individual
heterozygous for the SNP in their genomic DNA. This method displays the suppression
of one allele in the mRNA production pathway and thus, confirms that genomic
imprinting is occurring at the locus. To examine the imprinting status of neurotypical and
ASD human brain sub-regions, RNA was extracted with the RNeasy kit from Qiagen

Figure 32: Sequencing Analysis of TKTL1 SNP Present in Human Brain Sub-regions
A comparison of neurotypical female brain samples and ASD brain sub-regions for
monoallelic and biallelic expression. Neurotypical females appear to have imprinted
expression of TKTL1 in parietal tissue while ASD females appear to lose that imprinted
expression in the same tissue.
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and treated with Qscript mastermix (Quanta) to create cDNA for sequencing analysis on
the Sanger 3130 in the Center for Genome Innovation (CGI). Sequences were viewed
with Finch TV sequence viewer software and analyzed for the presence of SNPs in the
genomic DNA. SNPs were identified and compared to the cDNA sequencing results to
determine whether biallelic or monoallelic expression of the SNP in mRNA could be
observed. The results determined that in neurotypical female parietal brain, monoallelic
expression could be identified signifying genomic imprinting in this sub-region. In
contrast, female occipital brain displayed biallelic expression of the SNP across all
samples in neurotypical and ASD brain. Interestingly, ASD female parietal brain as
shown in Figure 32 displayed a loss of parietal region-specific imprinting compared to
their neurotypical counterparts.
Conclusions
Significant differences exist between neurotypical female brain and ASD female
brain in a subregion specific manner. The combination of the data showing a statistically
significant increase in relative expression of TKTL1 transcripts in ASD female parietal
brain and the loss of imprinting status points to a potential correlation between the loss
of the imprint and the development of this neurodevelopmental disorder. Moreover, it
supports the hypothesis set out by Skuse et al. indicating imprinted genes on the X
chromosome influence the cognitive ability of individuals2. To date, no confirmed
imprinted genes have been identified on the human X chromosome, however, my work
along with the work previously done by Dr. Addie Mae Nesbitt has provided preliminary
evidence of Transketolase-like 1 imprinting status not just on the mouse X
chromosome, but also on the human X.
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Several explanations could suggest why TKTL1 is not observed to be over
expressed in ASD male brain. First, a high post-mortem interval (PMI) is observed in
several brain samples, as seen in Figure S6. RNA degradation due to this high PMI
could account for skewed results in expression analysis. Excluding samples 1638 and
1349 as PMI outliers, the average difference between neurotypical and ASD males PMI
is higher than that of females in this study. With this fact, it is possible that RNA
degradation influenced the results as a source of error for the male brain samples more
substantially than the females. Also, when acquiring samples from the Neurobiobank,
there were inconsistencies among the labeled brain sections received, meaning a brain
subregion may have been incorrectly categorized before shipment. Additionally it is
worth noting that the cause of death of many of the subjects, asphyxiation related
causes, could be indicative of increased oxidative stress (Figure S6). Lastly, it is
possible that TKTL1 is not directly associated with ASD in males, and is female ASD
specific. Without being able to obtain precise brain sub-region samples from the
Neurobiobank, increasing the cohort was not possible. While an N=4 is a low cohort of
samples for statistical significance, these findings do suggest a pattern in female
parietal brain.
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Chapter 5: Characterization of the TKTL1 Protein
There is a debate in the literature about the
function of the protein Tktl1 (or in human TKTL1).
As stated previously, Coy et al.174 and Schenk et
al.194 postulate that TKTL1 is the rate limiting
enzyme in the PPP controlling the production of
metabolites in the non-oxidative phase. However,
Meshalkina et al. argues that TKTL1 does not itself

Figure 33: Tkt and Tktl1
Conservation. Pairwise protein
alignment of Tkt and Tktl1 in
mouse. Alignment done with
EMBOSS Water alignment tool.

even function as a canonical transketolase due to
a 38 amino acid residue deletion in the N-terminal region of TKTL1 that encompasses a
binding site for the essential co-enzyme, thiamine195. It has been shown that Tkt is
phosphorylated at a threonine at amino acid position 382 (Thr382) by protein kinase B
(Akt) and that this phosphorylation event is critical for Tkt function196. The
phosphorylation activation site, Thr382, is conserved between mouse and human Tkt and
Tktl1 proteins, as shown in Figure 33. This conservation could be a clue to the overall
function Tktl1 serves in the cell and ultimately the role it may play as a regulating
enzyme in the PPP. This chapter aims to elucidate the potential interactions of Tktl1 in
HT-22 mouse hippocampal cells and also in utero electroporation (UTE) transfected
mice.
Tktl1 maps approximately 500 kb from the Xlr3/4 cluster in mice and the human
ortholog TKTL1, is found in the syntenic region of the human X, mapping to Xq28. It is
not currently known if TKTL1 functions as a transketolase despite encoding for a
paralog of the autosomal transketolase gene, TKT197. In the PPP, transketolase is a rate
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limiting step in the reversible non-oxidative portion of the pathway, and it is critical for
providing the cell with ribose-5-phosphate for nucleotide synthesis and NADPH in
conditions of oxidative stress189,190. A disruption in NADPH production could result in
increased levels of free radicals, or reactive oxygen species (ROS). NADPH is required
to reduce cellular glutathione which in turn converts the ROS peroxide to water. ROS
are damaging to cells, nerve cells in particular, reacting with the lipid bilayer causing
lipid peroxidation and cellular death198. Oxidative stress has been investigated as a
causative factor of cellular degeneration by measuring the relative concentration of
detoxifying agents such as reduced glutathione along with lipid peroxidation
byproducts199,200. Incorrect regulation of TKTL1 imprinting in specific brain sub-regions
may alter transketolase activity, thus altering the ability for neurons to produce an
appropriate amount of reducing agents leading to increased oxidative damage and
neurodegeneration201.
A cell line derived from mouse hippocampus (HT-22) was used due to the
difficulty to culture and grow primary neuronal cell lines202. HT-22 cells grow effectively
in culture and can be easily transfected. In these experiments, transfection was
conducted with the Neon Transfection System from Thermo Fisher Scientific utilizing
electroporation. This method allows for plasmids and vectors to be transfected through
the cell membrane by electrical pulse203. A mouse model system to investigate the
enzyme reaction of the PPP was chosen due to high level of conservation between
human and mouse systems. Additionally, HT-22 cells serving as a model for human
cells undergoing oxidative stress and other disorders is well-documented in the
literature200,201,202. An expression construct developed by Dr. Nesbitt including the full-
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length coding DNA sequence for human TKTL1 was ligated into a pCAGGS vector (gift
from the J. LoTurco laboratory). The pCAGGS vector is controlled by a chicken β-actin
promoter and has been observed to be highly expressed in several cell types205.
TKTL1 Protein Interactions
Tkt is activated by the phosphorylation of Thr382 by Akt as part of the mammalian
Target Of Rapamycin (mTOR) pathway to produce sufficient growth factors,
extracellular nutrients and amino acids to allow proper cell proliferation 196. As stated
above, activated Tkt is an integral and rate limiting enzyme in the non-oxidative phase
of the PPP187. Due to the conserved Thr382 phosphorylation activation site present in
TKTL1, I decided to investigate the potential for interactions between the Akt kinase, Tkt
and TKTL1. The transfected construct contained human TKTL1 cDNA to allow it to be
distinguished from endogenous mouse Tktl1 in gene expression assays. My working
hypothesis was that human TKTL1 would work as a regulating factor for the activation
of endogenous Tkt in the cell. With the conserved Thr382 binding site, TKTL1 could act
as a competitive inhibitor by providing additional Thr382 sites for activation by Akt,
decreasing the amount of Tkt phosphorylation events and thus influencing the reversible
reactions of the non-oxidative phase of the PPP. In this way, aberrant TKTL1
expression could explain the increased levels of oxidative stress and provide a direct
link to the over expression of TKTL1 observed in female parietal brain and the
development of ASD.
To elucidate the potential for interactions between Akt/Tkt and Akt/hTKTL1 a
pCAGGS-hTKTL1 vector was transfected via electroporation into the HT-22 cell line and
transfected cells were assayed for expression of endogenous Tkt, hTKTL1 mRNA, and
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glucose-6-phosphate 1-dehydrogenase (G6pd). G6pd is another gene on the X
chromosome of the mouse that encodes a protein integral to the PPP. This gene was
used in expression experiments to demonstrate the transfection of hTKTL1 did not alter
the expression of other genes involved in the PPP. As is shown in Figure 34, the
pCAGGS promoter was able to drive hTKTL1 expression to high levels in transfected
HT-22, while not increasing expression of other genes involved in the PPP.
Relative Expression of Tkt, hTKTL1, G6pd in HT22 and HT22 Transfected
Cells
90.00

***

Average Fold Change

80.00

p Value = 0.00012
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Figure 34: qRT-PCR HT-22 Transfected Cell Lines
qRT-PCR results of pCAGGs-TKTL1 transfection in HT-22 cells. HT-22 control cells depicted
in blue and transfected +hTKTL1 HT-22 cells depicted in red. No statistical difference
observed in either Tkt or G6pd expression. Highly significant difference observed between
control HT-22 cells and +hTKTL1 transfected cells. T-Test ***p=0.00012 for transfected HT22 cells compared to control. All values normalized to β-actin.

To investigate protein-protein interactions, co-immunoprecipitation (co-IP) assays
were performed using an antibody to endogenous Akt. A co-IP utilizes an antibody of a
known protein, in this case Akt, believed to form a strong association with another
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protein creating a protein/protein complex. Using this antibody for an IP allows for both
proteins, if strongly bound, to be pulled down together. Instead of blotting for the known
protein, a second antibody against the potential associated protein is used during the
western blot, in this case, Tkt and TKTL1 respectively. It is then possible to assess the
protein/protein interactions of interest188. Protein complexes immunoprecipitated with
the Akt antibody were separated via polyacrylamide gel-electrophoresis and western
blotted. Western blots were treated with antibodies to either Tkt or TKTL1. As shown in
Figure 35, both Tkt and TKTL1 show protein/protein interaction with Akt. A modest but
significant decrease in interaction of Tkt with Akt in the transfected cell line was
observed compared with the control HT-22. Biological replicates were analyzed with
ImageJ for band concentrations and two tail p-value calculated by t-Test for paired two
sample for means with an alpha of 0.05. TKTL1 is detected interacting with Akt in the
transfected cell lines and not in the control HT-22 cells. This result suggests that over
expression of TKTL1 mRNA, and thus increased TKTL1 protein, may interfere with the
canonical interaction between the two proteins altering the efficiency of Tkt to function in
the PPP as proposed by my hypothesis.
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Figure 35: Co-IP of Tkt/Akt and TKTL1/Akt
Co-immunoprecipitation depicting the interactions between Akt with Tkt (A) and Akt with
TKTL1 (B). Modest decrease in interaction observed in Tkt, *p=0.015 (A) and a qualitative
interaction observed with Akt/TKTL1 (B). α-tubulin as loading control, normalized data show
protein/protein interactions with Akt. Concentrations of protein bands measured with ImageJ.
Histogram of densitometric quantification of band concentrations ratios to background and
normalized to loading control (D).

With the data suggesting that both Tkt and TKTL1 interact with Akt the next step
was to assess whether the phosphorylation status of Tkt was altered when TKTL1
mRNA was over expressed. To elucidate this, a protein immunoprecipitation with a
monoclonal Transketolase antibody (Thermo Fisher) and a polyclonal TKTL1 antibody
(Thermo Fisher) were used to pull down the protein of interest in an
immunoprecipitation. Following this, the PVDF membrane was blotted with a phosphothreonine antibody to quantify phosphorylation in protein present. My hypothesis was
that in control HT-22 cells phosphorylation of Tkt would be higher compared to that of
the transfected cells lines, suggesting hTKTL1 is interfering with phosphorylation of Tkt.
The interaction of Akt with hTKTL1 would also predict phosphorylation of hTKTL1 in the
transfected cells lines and little to no phosphorylation in the control HT-22 cells. Any
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detection of phosphorylation of TKTL1 in control HT-22 cells would likely be background
endogenous mouse Tktl1 cross reacting with the polyclonal antibody to hTKTL1.

Figure 36: Tkt and TKTL1 IP for Phosphorylation Analysis
HT-22 cell lines and hTKTL1 transfected cell lines showing differential protein quantification
after immunoprecipitation. IP with Tkt antibody and blotted for phospho-threonine (A)
**p=0.0067. IP with TKTL1 antibody and blotted for phospho-threonine (B) ***p=0.00064.
Total loading control (C) with α–tubulin primary antibody. After transfection, Tkt
phosphorylation (activation) is knocked down. TKTL1 phosphorylation is detected in
transfected cells. Histogram of densitometric quantification of band concentrations ratios to
background and normalized to loading control (D). Data suggests that the presence of
constitutively transcribed hTKTL1 in HT22 cells decreases the phosphorylation of
endogenous Tkt.

As seen in Figure 36, phosphorylation is decreased for Tkt in transfected HT-22
cell lines, concurrent with high expression and high levels of phosphorylation of TKTL1.
This data support the hypothesis that TKTL1 acts as a competitive inhibitor of Akt
phosphorylation of Tkt, thereby potentially inhibiting the non-oxidative phase of the PPP.
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Figure 37: Relative Ratio of Glutathione and NADPH in Cells
Relative ratio of GSD/GSSH (A) and NADPH (B) in mouse hippocampal cell lines, HT-22,
transfected with pCAGGS/TKTL1 vector. A statistically significant difference was observed
between control HT-22 cells and transfected cell lines over expressing TKTL1. Error bars
indicated a ninety-five percent confidence interval. Assays conducted by Amy Friss.

Interestingly, over expression of transketolase or transaldolase, both involved in
the non-oxidative phase of the PPP, has been linked to increased oxidative stress.
Schenk et al. along with Coy et al. have proposed and shown evidence that one of the
transketolase enzymes (Tkt or TKTL1) is the rate limiting enzyme in the non-oxidative
phase of the PPP175,176. Previous work done in the O’Neill lab by Amy Friss showed that
forced over-expression of TKTL1 in the mouse hippocampal cell lines, HT-22, reduced
the levels of glutathione and NADPH produced during the non-oxidative phase of the
PPP, see Figure 37. This reduction of glutathione and NADPH inhibits the neural cells’
ability to reduce ROS’s such as hydrogen peroxides and leads to oxidative stress and
ultimately neurodegeneration.
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To investigate the interaction of Akt/Tkt/TKTL1 in vivo, CD1 fetal mice were
transfected in utero with both the pCAGGS-hTKTL1 construct and pCAG-mRFP
(monomeric red fluorescent protein) in collaboration with Roman Goz in the laboratory
of Dr. Joe LoTurco186. Embryos were allowed to gestate until P0 and neocortex was
extracted at this time. qRT-PCR was conducted to confirm the presence of hTKTL1
transcript, as seen in the results in Figure 38. Immunoprecipitation was then performed
on protein extractions using antibodies to Tkt, hTKTL1 or Akt as a control in this
experiment. IP products were western blotted and stained with the antibody against
phospho-threonine. This assay was performed to determine if phosphorylation of Tkt is
inhibited by over expression of hTKTL1 in vivo. Figure 37 shows high expression of
hTKTL1 transcripts in two mouse IUE brain samples, 11 and 13, compared to the nontransfected control. Moreover, endogenous Tkt expression appears unaffected in the
transfected brains.
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Figure 38: qRT-PCR of Mouse IUE Brain Samples
Relative fold change of Tkt and TKTL1 in mouse IUE brain samples. A statistically significant
increase in expression was observed in IUE brain 11 and 13 compared to WT. Error bars
indicate 95 percent confidence interval.

Immunoprecipitation and subsequent western blots of protein extracts from brain
samples 11 and 13 are shown in Figure 39. Again, an increase in phosphorylation of
TKTL1 when over expressed was observed along with a decrease in endogenous Tkt
phosphorylation. Band concentrations were measured with ImageJ and an ANOVA
single factor test was used to calculate statistical significance between IUE brain
samples and WT. This data, combined with previously described protein data, provide a
compelling argument that TKTL1 can and does act in competition with endogenous Tkt
for phosphorylation. Inadequate levels of Tkt phosphorylation may lead to aberrant
production of PPP metabolites and contribute to the levels of oxidative stress present in
cells over expressing TKTL1.
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Figure 39: Mouse IUE IP Western Blot Analysis
Western Blot analysis on mouse IUE transfected samples compared to WT brain tissue. IP
with Tkt antibody and blotted for phospho-threonine (A). IP with hTKTL1 antibody and blotted
for phospho-threonine (B). Akt antibody used for total protein loading control (C). A decrease
in phosphorylated Tkt was observed in IUE mouse brains compared to wildtype with a
calculated *p-value=0.013. An increase in phosphorylation of hTKTL1 was observed in
mouse IUE brains with a calculated *p-value=0.027. Histogram of densitometric quantification
of band concentrations ratios to background and normalized to loading control (D). Akt used
as total protein loading control. Secondary anti-body was provided by Li-cor.

Conclusions
With the lack of knowledge in the literature about the function of the TKTL1
protein, providing insight into the role the protein plays in the PPP and the role of the
conserved phosphorylation site was important. Protein-protein competition altering
enzyme function has often been reported in the literature. This competition was clearly
defined by the Csn4–Bam–Bgcn competition model where these proteins antagonize
each other’s functions to regulate germ cell differentiation in D. melanogaster189. In
this system, Bam proteins are upregulated and sequester the Csn4 proteins from the
COP9 complex thus changing the function and allowing the cell to undergo
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differentiation rather than self-renewal. My data suggests that TKTL1 may very well
be acting in a similar fashion regulating the function of endogenous TKT in the PPP.
In normal cells, low level expression of TKTL1 may modulate phosphorylation of TKT
to achieve homeostasis. This would explain why TKTL1 is typically expressed at low
levels as to not cause adverse effects to the PPP and increase levels of oxidative
stress in the cell. However, when TKTL1 is over expressed in cancer cells, it is an
important component in mass producing nucleic acids via increased levels of
ribose190. Rapidly proliferating cancer cells increase glucose consumption as a
means to facilitate production of nucleotides and lipids191. Several studies have
shown TKTL1 to be a pivotal enzyme in the PPP in cancer cells and is hypothesized
to be upregulated to balance the production pentoses for nucleotide synthesis and
fatty acid synthesis, as well as maintaining homeostasis for oxidative stress191,192.
TKTL1 may very well function as a transketolase in the PPP in cancer cells as studies
have suggested. However, my experiments suggests a novel role for TKTL1 as a
competitive inhibitor of TKT in neural cells. While TKTL1 expression and function has
been well studied in cancer cells, its role in neural cells is currently unknown.
Cascante et. al193 observed increased TKTL1 expression in cancer cells as well as
increased activity of Akt and the mTOR signaling pathway. Increased Akt activation
would allow for phosphorylation of both TKT and TKTL1. Additionally, Cascante et al.
proposes TKTL1 functions in an independent one-substrate reaction converting
xyulose-5-phosphate to glyceraldehyde-3-phosphate. Since neural cells are not
rapidly dividing, TKTL1 may function differently compared to previous studies in
cancer cells. In fact, the glutathione assay conducted by A. Friss (Figure 37) directly
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contradicts TKTL1 functioning as a transketolase in neural cells. When TKTL1 is
aberrantly expressed in normal neural cells, such as female parietal brain, oxidative
stress and neurodegeneration may occur and lead to neurodevelopmental disorders
such as ASD.
Understanding how TKTL1 functions when it is over expressed in neuronal
cells such as in these experiments can provide insight to the function it serves in
neurotypical cells. This work has shown TKTL1 not only has a conserved Thr382 site
with Tkt, but that it can alter the levels of Tkt activation as well. While TKTL1 is a
relatively low expressed gene, it may be critical in modulating the function of the non oxidative phase of the PPP. TKTL1 and Tkt could work together as the rate limiting
enzymes in the PPP, based on phosphorylation activation. This data suggests TKTL1
regulates and when over expressed, inhibits, the activation of Tkt. Using this
antagonistic relationship between the two alleles, the cell is able to properly balance
the reversible reactions of the non-oxidative phase of the PPP to ensure oxidative
stress is kept low, while also producing metabolites for downstream functions such as
the production of DNA/RNA. As no studies to date have investigated the function of
TKTL1 in neural cells, this body of work serves as a novel insight into how TKTL1
functions within neural cells, and in particular how it can be used to regulate the PPP.
While TKTL1 may in fact not function as a transketolase itself due to the deletion of
the co-enzyme binding site, this study suggests it does play a role in overall
transketolase function within the cell. Additionally, the data suggests that when
TKTL1 is over expressed within neural cells, oxidative stress is increased and can
lead to neurodegeneration, and potentially, ASD.
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Chapter 6: Synthesis and Future Directions
The goal of past graduate students in the O’Neill lab has been primarily to
elucidate an imprinting mechanism regulating PSGE on the X chromosome in
mammals. This began with Dr. Raefski and his discovery of the imprinted Xlr3/4 cluster
in 20053. Using a Turner Syndrome model mouse, this study identified maternal specific
gene expression of the Xlr3b, Xlr4b, Xlr4c paralogs on the XA.7.2 region of the X
chromosome. The imprint was observed in different tissue types including brain and
fibroblast cell lines. Following this work Dr. Carone proposed that a novel imprinting
mechanism must exist regulating the imprinted cluster after providing evidence that a
DMR does not exist within the region of the imprinted paralogs.
Looking at the primary transcripts of Xlr3b Dr. Kasowitz identified a difference in
transcript abundance at the 3’ end that was not seen at the 5’ end when comparing the
maternal to paternal alleles. This suggested that the maternal copy of Xlr3b completed
transcription through initiation, elongation and termination while the paternal transcript
was interrupted after initiation. Building off of this work, Dr. Qureshi sought to
investigate the potential co-transcriptional regulation mechanism studying RNA Pol II
activity at the Xlr3/4/5 locus. Through his experiments he showed a perturbation of RNA
Pol II during active transcription first beginning at Int3/Ex4 and almost completely stalled
by intron 7. However, Dr. Qureshi’s results have not been able to be repeated by others
in the O’Neill lab. This previous work culminated in the study of various histone
modifications at the imprinted Xlr3/4 region to investigate if a differential chromatin
environment exists between the maternal and paternal allele potentially influencing
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active RNA Pol II transcription events. Prior to this dissertation, no robust, repeatable
difference in chromatin architecture has been observed.
Dr. Nesbitt established the foundation for the work investigating TKTL1 (Tktl1) in
both human and mouse. Dr. Nesbitt searched beyond the imprinted Xlr cluster in an
attempt to identify other imprinted genes on the mouse X chromosome. In doing so, she
identified the gene Tktl1 to be partially paternally imprinted in specific mouse tissues
including subregions of the neonatal brain. The unique finding by Dr. Nesbitt enabled
the lab to bridge the gap between the model mouse and the human genome since,
unlike the Xlr3/4 genes, Tktl1 has a human ortholog, TKTL1 that is also present in the
syntenic region of the human X chromosome174. Her work along with Amy Friss
identified Tktl1 to not only be imprinted, but also involved in the pathway of glutathione
reduction. This discovery linked an imprinted gene on the X chromosome to potential
downstream neurodegeneration and cognitive defects for the first time in our lab. I
began my work studying the relative expression of TKTL1 in human brain sub-regions to
test the hypothesis that individuals with ASD would aberrantly express TKTL1 and thus
would have neurodegenerative and social cognitive defects. I also set out to investigate
the function the TKTL1 protein plays in the Pentose Phosphate Pathway to test the
hypothesis that over expression of TKTL1 would decrease the phosphorylation and
activation of endogenous Tkt altering production of metabolites in the non-oxidative
phase of the PPP.
Nucleosome Positioning and the RNA Pol II Stalling
A thorough investigation of nucleosome positioning and occupancy has shown
that there are regions on the paternal allele of the imprinted Xlr genes that are highly
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nucleosome dense compared to the maternal allele, and that regions of the maternal
allele contain nucleosomes not present on the paternal allele. Specifically in Xlr3b,
nucleosomes are preferentially positioned proximal to the Int3/Ex4 boundary and within
intron 7 on the paternal allele. Although this is not a definitive answer to the stalling
machinery or imprinting control mechanism of X-linked imprinted genes, it does provide
a novel insight into how nucleosome positioning can potentially influence transcription
regulation on the X chromosome. Low levels of paternal mRNA transcripts are
detectable suggesting that RNA Pol II is able to overcome the nucleosome obstacles on
the paternal allele but at a relatively low success rate. Additionally, the presence of a
maternal nucleosome located at the G-quadruplex exon1/intron1 boundary suggest a
potential novel mechanism where H3.3 may be deposited on the maternal allele and not
the paternal allowing proper transcription initiation and elongation. H3.3 would only be
able to be deposited on the maternal allele alleviating the secondary G-quadruplex
structure and allowing proper transcription throughout the gene body. Conversely, on
the paternal allele, H3.3 would not be deposited in the region of G-quadruplex formation
and RNA Pol II would not be able to proceed effectively though the gene body.
A future characterization of transcription differences between the alleles could be
investigated by conducting a global run on sequencing (GRO-Seq) assay to determine
the status of RNA Pol II and the transcripts being produced from the maternal and
paternal alleles175. Since the paternal allele is not producing a full transcript, the
maternal sequencing results for the imprinted Xlr3/4 region should be statistically more
prevalent. Additionally, this assay would indicate the status of RNA Pol II across the
gene body for each of the imprinted paralogs providing a more in depth understanding
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about the stalling mechanism as a whole. Conducting this GRO-Seq experiment with
the Illumina Next-Seq would allow for a thorough investigation of the maternal and
paternal X chromosome and help identify other genes with a similar profile. This
process will map the quantity, orientation and position of actively transcribing RNA Pol
II.
An assay should be developed to destabilize the nucleosomes present on the
paternal allele to observe if full active transcription is restored to provide evidence that
nucleosome positioning is influencing transcriptional regulation. Nucleosome
destabilization has been used to allow nucleosomes to be more easily modified during
transcription176. One way to destabilize nucleosomes is to alter the salt concentration in
in vitro expression assays. Nucleosome binding affinity can be altered by increasing or
decreasing the overall salt concentration loosening or tightening the bound DNA
allowing for easier histone octamer sliding events195. If nucleosome binding affinity is
lessened and normal levels of transcription are restored, it could be concluded that
specific nucleosome positioning perturbs RNA Pol II and in effect, regulates
transcription of the imprinted cluster. It is important to thoroughly investigate this
nucleosome occupancy and RNA Pol II activity as a potential imprinting mechanism and
would require further evidence to conclusively characterize it as a novel imprinting
mechanism. GRO-Seq and a nucleosome sliding assay would greatly contribute to this
hypothesis.
An additional assay that would aide in deciphering the role of Gquadruplex/ATRX interactions would be a histone variant H3.3 ChIP-Seq. This
experiment would determine if there is differential deposition of H3.3 on the maternal
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allele compared to the paternal allele at the exon1/intron1 boundary. H3.3 is known to
be deposited in heterochromatic regions of DNA to allow for DNA accessibility for active
transcription177,178. If there is an enrichment of H3.3 at this locus on the maternal allele it
would explain how RNA Pol II is able to produce a full transcript of Xlr3b on the
maternal allele and explain why the paternal allele remains repressed. To determine if
this H3.3 deposition truly is the ICR controlling the imprint of Xlr3b, an assay would
need to be conducted to either remove H3.3 from the maternal allele where the
expected outcome would be transcription silencing, or add H3.3 to the paternal allele
where the expected outcome would be transcription activation of the paternal allele. An
RNAi construct could be created against histone variant H3.3 thus interfering with the
deposition on the maternal allele. In this assay, the hypothesis would be the maternal
allele would not produce a full transcript and would become silent.
The Model of Xlr3b Transcription Perturbation by Nucleosome Occupancy
For the purposes of this dissertation, the model of transcription perturbation
identifies nucleosome occupancy on the paternal X chromosome to regulate expression
at the Xlr3/4 imprinted gene cluster. The maternal allele of Xlr3b undergoes proper
transcription initiation, elongation and termination. The maternal copy is
hypermethylated at the promoter and transcription initiation events are observed
similarly to autosomal imprinted loci in the genome. Although the promoter region is
heavily methylated the pre-initiation complex (PIC) is able to be established successfully
and RNA Pol II begins to synthesize mRNA products198,199. This is followed by proper
transcription elongation and eventually termination at the 3’ end of the gene200.
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The paternal allele does not follow the same pattern of transcription elongation.
Previous data by Dr. Carone, Murphy and Kazowitz have suggested that the PIC is able
to successfully establish at the Xlr3b promoter and begin to synthesize mRNA. Early
transcription events occur equally on both the maternal and paternal allele up through
part of transcription elongation. Following this initiation of transcription, RNA Pol II
appears to be interrupted on the paternal allele failing to produce a full length paternal
transcript. As of yet, no mechanism or model has been reproducible to explain this
paternal silencing. The following model, shown in Figure 40, explains an imprinting
mechanism where differential nucleosome positioning may cause RNA Pol II to stop
and dissociate during active transcription on the paternal allele. A buildup of
nucleosomes results in the perturbation of RNA Pol II on the paternal allele followed by
dissociation. The following model provides a schematic of how nucleosome positioning
could cause RNA Pol II elongation perturbation and eventual dissociation from the DNA
strand. Weber et al.201 explains that nucleosomes are observed to create a barrier to
RNA Pol II transcription in vitro. This study showed that nucleosome occupancy has a
direct effect on the extent of RNA Pol II stalling and perturbation201. The ability of
nucleosomes to pause RNA Pol II transcription is well defined in the literature,
particularly at the promoter region. Gilchrist et al. noted highly regulated genes with
nucleosomes at the promoter that display RNA Pol II stalling, disfavor nucleosome
occupancy within the gene202. This data suggested a link between RNA Pol II competing
with nucleosomes for promoter occupancy and downstream positioning of nucleosomes
within the gene body. Nucleosome positioning at highly active gene sites has been
observed to create a stalling event just upstream of the transcribed gene region. This
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barrier is required to be overcome for downstream transcription to occur203. Wilhelm et
al. hypothesized that a pile up of nucleosomes at the intron/exon boundary could cause
RNA Pol II to slow down or pause204.

Figure 40: A Proposed Imprinting Mechanism Model Silencing the Paternal Xlr3b
Proper transcription initiation occurs on both the maternal and paternal alleles and actively
being transcribing mRNA. When RNA Pol II approaches int3/ex4, it encounters specifically
placed high affinity nucleosomes and begins to stall. This stall inhibits the ability of the
transcription machinery to recruit chromatin remodelers and thus creates an environment
difficult for the machinery to transcribe through. Some RNA Pol II is able to overcome the
first obstacle, but further downstream RNA Pol II encounters another region of high affinity
nucleosomes at intron 7 and the majority of RNA Pol II is stalled and dissociated truncating
transcription and causing the silencing of the paternal Xlr3b transcript.

An alternative model for the Xlr imprinting cluster could involve a G-quadruplex
recruitment of ATRX on the maternal allele leading to the deposition of H3.3 to provide
active RNA Pol II transcription at the 5’ end of the Xlr3b gene body. This novel
mechanism would explain how the maternal allele is expressed more freely while the
paternal allele remains repressed. In this model seen in Figure 41, a G-quadruplex at
the exon1/intron1 boundary of the Xlr3b gene body would recruit ATRX to the region
where there is a differential nucleosome occupancy between the maternal and paternal
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alleles. The maternal allele which has an observed nucleosome located at this locus
would allow ATRX to deposit H3.3 to promote active transcription of the allele.
Conversely, the paternal allele, would contain no nucleosome placed at this Gquadruplex region and would not allow deposition of H3.3 and would inhibit the ability of
proper transcription elongation of the allele in a parent specific manner. This novel
mechanism would be the first of its kind on the X chromosome to describe a genomic
imprinting region utilizing ATRX at a G-quadruplex to regulate parent specific gene
expression. Additionally, the Shioda group identified a small CG rich region that
displayed differential methylation in their male ATRX knockout mice. In the study, ATRX
KO mice displayed a decrease in methylation at the region compared to WT 178.
Although this region is not a classically identified CpG island, this differential
methylation of the region could be involved with the imprinting mechanism. However,
previous work by Dr. Carone and Dr. Murphy did not detect differential methylation in
this region.
Additionally, the transcription factor complex, FAcilitates Chromatin Transcription
(FACT), is essential for chromatin remodeling and proper transcription through
nucleosomes205. When RNA Pol II stalls at the 5’ region of genes, H3K36me3 also piles
up with the transcription machinery. Set2, a histone methyltransferase, modifies
histones with H3K36me3 in coordination with RNA Pol II during transcription
elongation206,207. If H3K36me3 cannot be recruited properly, i.e. due to a lack of a
nucleosome, FACT recruitment will also be altered and the ability of active transcription
could be drastically diminished. This may be involved with the perturbation of RNA Pol II
on the paternal allele along with overcoming a G-quadruplex on the maternal allele.
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Figure 41: Proposed Alternative Imprinting Mechanism Model for Xlr3b
Proper transcription initiation occurs on both the maternal and paternal alleles and
actively being transcribing mRNA. However, at the exon1/intron1 boundary a
nucleosome is positioned on the maternal allele and not the paternal allele. This
positioning difference allows for ATRX, which is recruited to the G-quadruplex region of
the gene body and deposits H3.3 to regulate active gene transcription. Conversely, on
the paternal allele, this nucleosome does not exist at the exon1/intron1 boundary and
thus does not allow for H3.3 deposition and transcript regulation is decreased due to
RNA Pol II difficulty transcribing through the region. This is exacerbated further down the
gene body by a pile-up of nucleosomes on the paternal allele perturbing any residual
RNA Pol II from successfully transcribing the Xlr3b transcript and thus silencing the
paternal allele.

TKTL1 Expression in Human ASD Brain Sub-regions
Oxidative stress has been closely linked to the development of
neurodegenerative disorders such as ASD208,209,210. The literature has connected over
expression of TKTL1 to increased levels of oxidative stress in certain cancers including
colorectal211 and several carcinomas212. TKTL1 upregulation has been identified as a
necessary event for tumor cells to proliferate and degrade glucose through the
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anaerobic transketolase-dependent PPP, known as the Warburg effect, for tumor cell
proliferation189. Due to this link to the PPP and production of substrates through the
degradation of glucose, TKTL1 is also linked to cellular oxidative stress by influencing
the reduction of glutathione to interact and reduce reactive oxygen species in the
cell208,209,210. This role directly links Transketolase activity to the development of
neurodegenerative disorders such as ASD along with cancer9. When I analyzed the
relative expression of TKTL1 I expected to find over expression prevalent in autistic
males due to the approximately 5:1 ratio of ASD in males to females1. However, the
data showed no statistical significance in either parietal or occipital brain tissue for
autistic males but did show a statistically significant difference in TKTL1 expression in
autistic female parietal brain samples. This observation can be explained by the Female
Protective Effect20 which states that females require a greater etiologic load to manifest
autistic behavioral impairment and thus this upregulation of TKTL1 in males may be
embryo lethal or so detrimental that the outcome is not ASD, but a more severe
neurological disorder. Another possible explanation is that male samples obtained for
this study were collected at varying post mortem intervals (PMI), and among them there
was a high rate of asphyxiation related causes of death. These factors could have made
it more difficult to observe a statistically significant difference in male TKTL1 expression
assays. It has been hypothesized in the literature that a single X chromosome locus
could mediate the Female Protective Effect and in turn produce the male sex bias
observed in ASD21. This also supports the hypothesis of Skuse et al. that there are
imprinted genes on the X chromosome responsible for deficits in neurocognitive ability2.
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An approximate 3-4 fold increase of relative TKTL1 expression was observed in
brain samples from autistic females obtained from the Neurobiobank. This data
suggests a sub-region specific increase of TKTL1 may contribute to the etiologic load in
females resulting in the development of neurodegenerative disorders such as ASD. Dr.
Nesbitt had previously identified TKTL1 to be imprinted in human fetal brain and this
imprint could support the Skuse hypothesis of imprinted X chromosome genes
influencing neurocognitive acuity. Data of this imprint was also supported by my SNP
identification assay where monoallelic expression of TKTL1 was observed in
neurotypical female parietal brain samples while biallelic expression was observed in
ASD female parietal brain samples. This data suggests that there is a genomic imprint
of TKTL1 on the human X chromosome even in adulthood and a subregion-specific loss
of this imprint could lead to aberrant expression of TKTL1 and eventually the
development of neurodegenerative disorders.
It would be important to investigate these findings in a larger representative
sample of individuals to give higher confidence this effect is taking place. An N=4 for
both female neurotypical and ASD brain samples does suggest a pattern of expression
for TKTL1. Repeating these experiments with additional cohorts would greatly increase
the significance of the finding and add to the overall knowledge of female ASD
development and potential therapeutic interventions in the field. However, it would be
important to ensure the samples provided were from identical brain sub-regions.
Another further experiment that would provide insight into the development of ASD
would be RNA-Seq. Using the Illumina Next-Seq to sequence the RNA profile of ASD
brain sub-regions would give an overall view of transcript differences across the entire X
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chromosome. Comparing neurotypical brain RNA-Seq data to ASD data would provide
inferences to differentially expressed regions and genes on the X chromosome and
would allow for identification and further analysis of gene targets. Understanding the
development of ASD is very important with the pervasive nature of the disorder and a
larger sample size along with RNA-Seq would contribute to the collective knowledge in
the field of ASD.
TKTL1 Protein Function and Influence on Endogenous Tkt
As previously discussed, transketolase is a rate limiting enzyme in the PPP
regulating production of products to ensure proper cell homeostasis during the nonoxidative phase158,171. TKTL1 has been implicated in neurodegenerative disorders such
as ASD and schizophrenia along with several forms of cancer including colorectal,
breast and other carcinomas189,190. However, the overall function and role of the protein
itself is not well classified in the literature. In fact, there is a disagreement whether
TKTL1 even maintains functional transketolase activity152. With this lack of knowledge in
the literature, investigating the function of TKTL1 and determining its role in the PPP
was important to this body of work. To do this I transfected HT22 hippocampal mouse
cell lines with the human TKTL1 cDNA transcript. In doing this I aimed to elucidate the
relationship between TKTL1 and endogenous Tkt. Previously in this dissertation TKTL1
and Tkt were explained to share a conserved phosphorylation site, Thr382, which has
been shown to be essential for Tkt activation and proper function. Akt as part of the
mTOR pathway phosphorylates Tkt at Thr382 activating the enzyme and allowing it to
function properly in the PPP catalyzing reactions of substrates in the non-oxidative
phase145. Knowing this phosphorylation is essential for Tkt activation, I hypothesized
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that because of the conserved Thr382 domain, TKTL1 would act in competition with Tkt
for phosphorylation and thus reduce the presence of activated Tkt in cells. As the data
showed, TKTL1 was in fact phosphorylated by an interaction with Akt and subsequently
the total amount of phosphorylated Tkt was reduced.
Additionally, transgenic mice were generated with the help of Roman Goz of the
LoTurco laboratory. CD1 fetal mice expressed TKTL1 transcript within the brain after In
Utero Electroporation (IUE). Extracting the brain tissue from these mice at P0, the
interaction of TKTL1 and Tkt was investigated in vivo and the same competitive
phosphorylation was observed. A constitutively active TKTL1 construct could be
engineered to over express TKTL1 specifically in mouse brain. This experiment would
generate transgenic mice with a similar expression profile to female ASD individuals
and could be used to further investigate the effects of TKTL1 over expression on the
PPP and overall brain development. Potentially this model could be used for behavioral
studies to determine if the mice present an ASD phenotype by decreased learning,
repetitive behavior, and social deficiency.
A transgenic Tkt knock-out cell line could be generated to study the function of
Tktl1. To elucidate whether Tktl1 truly maintains the transketolase activity, these cell
lines could be treated with an integrating Tktl1 expression vector to determine if over
expressing Tktl1 would rescue the cell line, thus proving that Tktl1 can in fact function
as a transketolase in the PPP. This could prove to be a difficult experiment as knocking
out Tkt would potentially drastically inhibit the cells ability to proliferate 213. However, if
Tktl1 is able to rescue the cell line and allow them to proliferate it would provide
substantial evidence supporting Tktl1 transketolase activity. With how pervasive TKTL1
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is in the literature relating to such prevalent disorders such as ASD and cancer, it is
important to examine the function of the protein thoroughly. Thus far in the literature, the
overall function of the protein has yet to be classified and these transgenic models
would contribute to the knowledge of TKTL1 in the field and provide crucial insight to the
role the gene plays in both neurodegenerative disorders and cancer.
The following models (Figures 42&43) depict the proposed competition observed
in the data examined in this dissertation. The data suggests that TKTL1 actively
competes with Tkt for phosphorylation by Akt. This competition inhibits the activation of
Tkt and ultimately leads to higher levels of oxidative stress in the cell due to the inability
of Tkt to function properly in the non-oxidative phase of the PPP. This lack of catalyzing
reactions results in a decrease in NADPH production lowering the amount of reduced
glutathione able to interact and reduce reactive oxygen species like hydrogen peroxide.
High levels of ROS in the cell leads to oxidative stress, lipid peroxidation, and
neurodegeneration. This provides the first direct link in the literature between TKTL1
and how it potentially leads to the development of neurodevelopmental disorders such
as ASD.
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Figure 42: Model of Typical TKTL1 Phosphorylation
Endogenous Tktl1 is expressed in low levels in mouse. When properly regulated and
expressed, it does not interfere with the phosphorylation and activation of Tkt by Akt and
activated Tkt is able to function properly in the PPP. Tkt limits the reaction and conversion
between Ribulose 5-phophate and Glucose 6-phosphate and regulates the production of
NADPH and reduced glutathione.
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Figure 43: Competition Model of Over Expressed TKTL1 in the PPP
Over expression of TKTL1 in the cell creates a competition for Akt phosphorylation. When
TKTL1 is over abundant, Akt will phosphorylate TKTL1 instead of endogenous Tkt.
Phosphorylated TKTL1 is then responsible for catalyzing the reaction in the non-oxidative
phase of the PPP. Even if TKTL1 retains the transketolase active, over expression will alter
the precursors and products in the PPP. This can result in deleterious effects to NADPH
production and lower the amount of reduced glutathione that is able to function as an
antioxidant and reduce ROS lowering oxidative stress. This model displays a potential
pathway for the increase of oxidative stress in neurons and eventual neurodegeneration
seen in disorders such as ASD.
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Chapter 7: Materials and Methods
Animal Breeding and Tissue Collection
All mouse protocols were approved by the University of Connecticut Institutional
Animal Care and Use Committee. A breeding scheme was used to generate Xmonosomic mice with a C57 strain background, (Figure 3). C3H/Paf males were mated
to C57BL/6J females to produce 39, XM mice. C3H/In(X) females were mated with
C57Bl/6J males to produce 39,XP mice. Neonates were inspected visually to initially
determine sex. A DNA extraction from limb tissue was conducted for PCR genotyping
using proteinase K digestion. A Y chromosome specific primer set, Smcy, was used to
definitively sex the mice. The DXMit130 marker primer set was used to determine
between the C56 and C3H X chromosome.

RNA Extractions
Tissue was extracted from mouse, flash frozen in liquid nitrogen, and stored at 80 until use. Human brain tissue was obtained already frozen from the Chuahan lab and
from the Maryland Brain Bank and stored at -80. Brain tissue from both mouse and
human were finely chopped with a scalpel and resuspended in buffer. Tissue and cell
pellets were extracted with Qiashredder (Qiagen) and RNeasy spin columns (Qiagen)
and suspended in DI water.

Bisulfite Sequencing
Chromatin was extracted from mouse 39,XM and 39,XP brain tissue samples.
Samples were treated with bisulfite conversion reagent (Zymo) at 42°C overnight.
Samples were purified and amplified using bisulfite primer sets designed with Zymo
Bisulfite Primer Seeker (Primer Table). Samples were run on the Sanger 3130 and
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sequence peaks were viewed with FinchTV. Methylated DNA diagrams were generated
using BiQ Analyzer from the Max Planck Institute bioinformatics.

Quantitative Real-Time PCR
SYBR Green Supermix (Quanta was used to perform qRT-PCR. Each sample
was conducted in triplicate with a 15 uL reaction volume on an IQ thermocycler from
BIORAD. The following protocol was used on the cycler; initial denature (95°C for 5
min); amplification step (95°C for 10 s, 62°C for 20 s, 72°C for 20 s); and final extension
step (72°C for 5 min). All primers used for qRT-PCR are provided in the supplemental
table of primers. Melt curves and CT values were analyzed using CFX Manager from
BIORAD for multiple products and primer efficiency. CT values were determined and
normalized using the relative expression ratio mathematical model (Pfaffl). Significance
was calculated with a T-Test.

Micrococcal Nuclease Treatment
Chromatin was extracted from neocortex of three 39,Xm individuals and three
39,Xp individuals via Phenol Chloroform/Isoamyl extraction. The chromatin was digested
with 0.5 units of micrococcal nuclease (NEB, MNase) for one hour at 37°C followed by a
proteinase K digestion leaving only previously nucleosome bound DNA. DNA was
suspended in DI water and analyzed on the Bioanalyzer DNA chip for library size
quality. Expected samples sizes were for 147 bp fragments.

SureSelect Target Enrichment
Custom SureSelect (Agilent) cRNA baits were created using the SureDesign
Tool (Agilent). Baits were created on the Mus Musculus X chromosome from
chrX:(70,319,680-70,535,867) from the mm9 build (NCBI 37.1). cRNA baits were

106

hybridized according to Agilent SureSelect protocol binding previously treated MNase
digested DNA samples and suspended in DI water.

Illumina Mi-Seq Sequencing
SureSelect target enrichment samples were used to create Illumina Mi-Seq
libraries. Six libraries were made for the three 39,Xm, and three 39,Xp brain tissue
samples. Custom SureSelectXT for Illumina Mi-Seq was used to generate libraries.
Illumina Mi-Seq adapters were added and sequences were paired end. Libraries were
quantified on the Bioanalyzer using a DNA HS chip (Agilent). Samples were loaded onto
Mi-Seq with the help of Dr. Bo Reese of the CGI.
Initial data was analyzed with a FastQC report to assess the quality of the run.
Bowtie2 was used to map Mi-Seq reads to the Mus musculus mm10 build (GRCm38) as
a reference index genome. Mapped reads were then analyzed with the R packages
NucleR and PING. PING generated a nucleosome positioning map utilizing peak
detection. NucleR generated a bed file of the nucleosome positions that could be
uploaded to UCSC and compared to other functional elements in the genome.
Bedsubtract was used to generate uniquely mapped reads for the XM and XP alleles.
NormR was also be used to normalize sequencing data and call enrichment of peaks.

Bionano Genomics Methylation Protocol
DNA was extracted from mouse 39,XM and 39,XP neonatal fibroblast tissue
cultures. Agarose plugs were made for high molecular weight extraction using the
CHEF Mammalian Genomic DNA kit (BIORAD) Cells were harvested and pelleted in
collection tubes at 1000 RPM for 5 minutes. Following this, the plugs are washed with
Wash Buffer and TE Buffer for iterations of 10 minutes at 43°C. Cells are embedded
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into agarose in a 15 minute incubation at 4°C. Next, there is a 2 hour proteinase K
digestion at 50°C followed by an overnight digestion also at 50°C. Plugs are washed
with wish buffer while shaking for a total of 2.5 hours at room temperature. The agarose
plugs are then melted during a 2 minute incubation at 70°C. Agarose is digested with
agarase during a 45 minute incubation at 43°C followed by a drop dialysis for 45
minutes at room temperature. DNA is homogenized overnight at room temperature to
get into solution. A dialysis membrane is used to isolate high molecular weight (HMW)
DNA. A Qbit Broad Range DNA analysis determines the concentration of the HMW
DNA. 300 ng of DNA digested with cofactor Adocf640 and M.TaqI enzyme for five hours
at 65°C. Proteinase K is added for two hours at 45°C.
The NLR reaction consists of a nick, label and repair. HMW DNA is nicked with
the BspQI enzyme for two hours at 37°C. The reaction then is labeled with the Bionano
labeling mix for one hour at 72°C. Finally the reaction is repaired with ligase for thirty
minutes at 37°C. The DNA backbone is stained with the Bionano staining mastermix
overnight at 4°C. The NLR reaction is quantified using the Qbit DNA HS assay.
The sample is loaded onto the Bionano Irys and a sample specific loading
protocol is produced with via assisted loading on the machine. Molecules are identified
by the program AutoDetect and data is analyzed on IrysView, Bionano Access and
IrysExtract.
Illumina NextSeq OMNI-ATAC-Seq
Mus musculus 39XM and 39XP neonate neocortex were extracted from mice.
Tissue was homogenized in 1x Homogenization buffer with Dounce homogenizer.
Nuclei were isolated through gradation by layering 35%, 29%, and 25% Iodixanol
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solution, separating cellular debris and the nuclei band. Nuclei were counted with
Trypan blue staining and 50,000 nuclei (Mus musculus) and 500 (Drosophila) nuclei
(spike in) were treated with ATAC-Seq Resuspension buffer followed by transposase
reaction buffer to attach preloaded Illumina adapter sequences. Samples were PreAmplified for 5 cycles with 2x NEBNext Master Mix and Illumina adapter and index
primers (Primer Table). Cycling conditions; 72°C for 5 minutes, 98°C for 30 seconds,
followed by five cycles of 98°C for 10 seconds, 63°C for 30 seconds and 72°C for 1
minute. A qPCR reaction was conducted to assess additional cycles needed for
amplification. Cycling conditions; 98°C for 30 seconds followed by 20 cycles of 98°C for
10 seconds, 63°C for 30 seconds and 72°C for 1 minute. Guidelines followed for
amplification found in Buenrostro et al 2015 (PMID: 25559105). Library was quantified
with KAPA Library Quantification kit and run on Illumina NextSeq with High-Output kit
2x75 paired end reads.
Initial data was analyzed with a FastQC report to assess the quality of the run.
Bowtie2 was used to map Mi-Seq reads to the Mus musculus mm10 build (GRCm38) as
a reference index genome. Mitochondrial reads will be removed before building the
genome index. Peaks will be called using MACS2 and compared similarly as ChIP-Seq
data for enrichment between 39XM and 39XP samples. DNA footprint analysis will be
conducted with ATAC-Seq pipeline according to Kundaje lab script on GitHub.
Nucleosome positioning was analyzed using NucleoATAC developed by the
Greenleaf lab at Stanford University generating nucleosome occupancy maps.
Following that, DNA footprint analysis was conducted with the MEME suite to detect
transcription factor binding proteins within the Xlr3b open chromatin DNA.
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Transfection
Mus musculus hippocampal neuronal cell lines (HT-22) were cultured in
complete mouse media. A pCAGGs hTKTL1 plasmid (gift from Dr. Loturco and altered
by Dr. Nesbitt for hTKTL1) was transfected into cells with the Neon Transfection System
(ThermoFisher). Cells were viewed under CKX41 (Olympus) florescent microscope to
confirm the presence of GFP expressing cells to calculate transfection efficiency. Cells
were harvested in cell pellets and divided into tubes for RNA and protein extraction.
qRT-PCR was performed on cDNA to confirm upregulated expression of human TKTL1
in transfected mouse HT-22 cells.

Western Blot
Protein was extracted from HT-22 cell pellets with Laemmli lysis buffer and
protease inhibitors. Laemmli loading buffer was added to protein samples and incubated
at 95°C for 5 minutes before loading in gel. 12% SDS page gels were made with the
SureCast system (ThermoFisher) with a 4% stack for wells. Samples were loaded and
ran at 125V for 90 minutes. Samples were then transferred to a PDVF membrane by
wet transfer with the ThermoFisher SureCast System at 20V for 60 minutes.
Membranes were allowed to dry for 1 hour at room temperature to allow proteins to
properly bind to the membrane. Following this membranes were reactivated in methanol
for 1 minute and blocked in 50% Licor Blocking Buffer and 50% 1X PBS for 1 hour.
Membranes were blotted with 1° antibody at a dilution of 1/1000 in a 50% Licor Blocking
Buffer and 50% 1X PBS solution with 0.01% Tween for 1.5 hours at room temperature.
Membranes were then washed 4x 5 minutes in 1X PBS + 0.1% tween. The 2° antibody
was added in a 1/10000 dilution same blocking solution with 0.1% tween. Membranes

110

were then washed 4x for 5 minutes in blocking solution with tween followed by a final
wash in 1X PBS for 5 minutes. Western blots were imaged and analyzed on the Licor
system using a Chameleon Duo protein ladder. Densitometry calculations were
conducted with ImageJ following the ImageJ protocol for subtracting background.

111

Appendices

A

B

C

D

Figure S1: MNase-Seq Quality Score:
Average read quality for 39XM sample Xm73 (A) and 39XP sample Xp100 (B). Sequence
length observed ~150 bp for majority of reads in 39XM sample Xm73 (C) and 39XP sample
Xp100 (D).
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Figure S2: ATAC-Seq Run Quality Report
The average read quality for (a) 39,XM and (b) 39,XP samples approximately 35 on the
Phred+33 scale. A high quality Phred+33 score exists for both (c) 39, XM and (d) 39, XP
pools meaning only adapter trimming will be necessary for these reads. The read length
going into mapping for (e) 39, XM and (f) 39, XP samples is distinctly 75bp.
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Figure S3: pCAGGS Vector Map
Vector used for transfections and IUE protocols of hTKTL1 cDNA transcripts. Commercially
available. Utilized glycerol stocks from Dr. Nesbitt and Amy Friss.
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Figure S4: 39,XM ATAC-Seq Quality Metrics
(A) Proximal Transcription Start Site (TSS) enrichment. Represents enrichment around
individual TSS’s. (B) Represents aggregated enrichment at all TSS’s. (C) Fragment length
distribution of ATAC-Seq reads. Majority of sequences within nucleosome free regions
(<150 bp) ~75 bp. (D) Signal correlation to roadmap DNase (ENCODE) from several
sample types measured by the Spearman’s Correlation. The closer the sample is in signal
distribution in the regions to your sample, the higher the correlation. Of note, the highest
correlated tissues are all members of the central nervous system (CNS).
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Figure S5: 39,XP ATAC-Seq Quality Metrics
(A) Proximal Transcription Start Site (TSS) enrichment. Represents enrichment around
individual TSS’s. (B) Represents aggregated enrichment at all TSS’s. (C) Fragment length
distribution of ATAC-Seq reads. Majority of sequences within nucleosome free regions (<150
bp) ~75 bp. (D) Signal correlation to roadmap DNase (ENCODE) from several sample types
measured by the Spearman’s Correlation. The closer the sample is in signal distribution in
the regions to your sample, the higher the correlation. Again, the highest correlation exists
within neurological CNS tissues.
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Sample ID
1174
1182
1638
4671
1407
1706
1708
1846
0797
1349
4231
4849
4899
5027
1185
1500
4645
4670
4722
4898

Age
7.8
9
20.8
4.6
9.1
8.6
8.1
20.6
9.3
5.6
8.8
7.5
14.3
38
4.7
6.9
39.2
4.6
14.5
7.7

Sex
F
F
F
F
F
F
F
F
M
M
M
M
M
M
M
M
M
M
M
M

Disorder
ASD
ASD
ASD
ASD
Control
Control
Control
Control
ASD
ASD
ASD
ASD
ASD
ASD
Control
Control
Control
Control
Control
Control

Cause of Death
Multi-system failure
Smoke Inhal.
Seizure-related
Fall
Asthma
Transplant rejection
Car Accident
Car Accident
Drowning
Drowning
Drowning
Drowning
Drowning
Bowel obstruct.
Drowning
Car Accident
Heart disease
CC accident
Car Accident
Drowning

PMI
14
24
50
13
20
20
20
9
13
39
12
20
20
26
17
18
12
17
16
12

Figure S6: Table of Neurotypical and ASD Brain Sub-Region Samples
Table depicts subject ID’s and related information for samples. Of note for this body of
work, the high prevalence of drowning or asphyxiation related causes of death and Postmortem interval (PMI).
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Primer Table
Primer Name

Sequence

Ad1_noMX
Ad2.1_TAAGGCGA

AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTCAGATGTG
CAAGCAGAAGACGGCATACGAGATTCGCCTTAGTCTCGTGGGCTCGGAGATGT

Ad2.2_CGTACTA
Ad2.3_AGGCAGAA

CAAGCAGAAGACGGCATACGAGATCTAGTACGGTCTCGTGGGCTCGGAGATGT
CAAGCAGAAGACGGCATACGAGATTTCTGCCTGTCTCGTGGGCTCGGAGATGT

Ad2.4_TCCTGAGC
G6pdx_Ex8_F1
G6pdx_Ex9_R1
Gapdh_Mus_Ex2_F2

CAAGCAGAAGACGGCATACGAGATGCTCAGGAGTCTCGTGGGCTCGGAGATGT
GGAGAAGCTGCCAATGGATA
CCAGGCTTCTTGGTCATCAT
ACTCCACTCACGGCAAATTC

Gapdh_Mus_Ex3_R2
Hsa_TKTL1_3'UTR_F5

GTGGTTCACACCCATCACAA
TTGGCCTCTTTACCCTGTGT

Hsa_TKTL1_3'UTR_R5
Hsa_TKTL1_5'UTR_F4

CCTAACAAGCTTTCGCTGCT
GAGCCCTTTTGAGATTGCAG

Hsa_TKTL1_5'UTR_R4
Mus_Tktl1_Ex1_RT_F1

CCCAGTGCGTTTATGTGATG
GTTCCATCAAGGCCACAAAT

Mus_Tktl1_Ex12_RT_F3
Mus_Tktl1_Ex13_RT_R3

ACAGGTGGCCGAATTATCAC
AGATGCATTTCACAGCCACA

Mus_Tktl1_Ex3_RT_R1
Mus_Tktl1_Ex5_RT_F2

TAGTCCTTGTCCAGGCCATC
AGCTCAAGTGAGAGGCAAGC

Mus_Tktl1_Ex6_RT_R2
TKT_Hsa_Ex2_F

TGAGGCGAGTCCTCAATAGG
CACACCATGCGCTACAAGTC

TKT_Hsa_Ex4_R
Tkt_mus_3'UTR_F1

GTCGAAGTATTTGCCGGTGT
AGGTCCCACAACTCCTCCTT

Tkt_mus_3'UTR_R1
TKTL1 3' 1F

GCCCTAAGATCACCCACTGA
TTTGGCCTCTTTACCCTGTG

TKTL1 3' 1R
Tktl1 E1F

CAGAAGGCACGTGCTGAATA
GCTAGTGCCGGAACTTTTTG

Tktl1 E1R
TKTL1_ex11_R

TAGTGCCTCGCTGCCATCTA
GCTTTTGCACTGGAGACGAT

TKTL1_ex9_F
Tktl1_F19a

GACCACCCGACCAGAAACTA
AGCTCAAGTGAGAGGCAAGC

TKTL1_Hsa_5'SNP_1F
TKTL1_Hsa_5'SNP_1R

GCTAGTGCCGGAACTTTTTG
TGGCCATATCTTGCAACACC

Tktl1_mus_F23
Tktl1_mus_F46
Tktl1_mus_R23
Tktl1_mus_R46

CCACCCCTACTGCACTGATT
CAACACACATTTGCTTTACT
ACACCAGAAGAGGGCATCAC
CACCTTTGTTCCACATTCAGA

TKTL1_Pro_SNP_F1
TKTL1_Pro_SNP_R1

GCTAGTGCCGGAACTTTTTG
CAACCCCTTTGGAGTCTGAA

Tktl1_R19

TGAGGCGAGTCCTCAATAGG
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Antibody Table
Antibody Name

Company

Catalog

AKT Pan Monoclonal Antibody
Phospho-Threonine Antibody (P-Thr-Polyclonal)

Thermo Fisher
Cell Signaling Technology

MA5-14999
9381

TKTL1 Polyclonal Antibody
β-Actin Antibody N-21

Thermo Fisher
Santa Cruz

PA5-28977
sc-130656
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